IKZF1

Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0003700 DNA-binding transcription factor activity	IBA GO_REF:0000033	ACCEPT	Summary: Ikaros is a well-established DNA-binding transcription factor that binds a/gGGAA motifs via its N-terminal zinc fingers and modulates transcription of target gene sets in lymphocytes. The IBA annotation at this level is appropriate. However, given that Ikaros predominantly acts as a transcriptional repressor via NuRD recruitment, the more specific term GO:0001227 (DNA-binding transcription repressor activity, RNA polymerase II-specific) would be more informative for the primary function. Ikaros can also activate some genes, so GO:0003700 is not wrong as a general annotation. Reason: Ikaros is unambiguously a DNA-binding transcription factor. The IBA annotation from phylogenetic inference is well-supported by extensive experimental evidence from multiple publications demonstrating sequence-specific DNA binding and transcriptional regulation. This term is at the right level of generality since Ikaros can both repress and activate transcription depending on context. Supporting Evidence: PMID:8543809 The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse PMID:23071339 Ikaros is a zinc finger-containing DNA-binding protein that plays a pivotal role in immune homeostasis through transcriptional regulation of the earliest stages of lymphocyte ontogeny and differentiation file:human/IKZF1/IKZF1-deep-research-falcon.md Ikaros is a C2H2-type zinc finger transcription factor that serves as a master regulator of hematopoietic cell differentiation, particularly lymphocyte development
GO:0006357 regulation of transcription by RNA polymerase II	IBA GO_REF:0000033	ACCEPT	Summary: Ikaros regulates transcription of genes transcribed by RNA polymerase II, including genes involved in lymphocyte development (IL7R, FLT3, NOTCH1, RAG1, DNTT, HDAC9). This IBA annotation is well-supported by the known biology. Reason: As a DNA-binding transcription factor targeting Pol II-transcribed genes in lymphoid cells, Ikaros is clearly involved in regulation of transcription by RNA polymerase II. The IBA is phylogenetically sound and well-supported by experimental data. This is a core biological process for Ikaros. Supporting Evidence: PMID:10204490 Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes [Ikaros targets NuRD and BAF complexes to regulate transcription] PMID:23071339 SYK-induced Ikaros activation is essential for its nuclear localization and optimal transcription factor function
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding	IBA GO_REF:0000033	ACCEPT	Summary: Ikaros binds specific a/gGGAA DNA motifs in cis-regulatory regions (enhancers and promoters) of target genes. This has been demonstrated by EMSA, ChIP-seq, and structural studies. The IBA annotation is well-supported. Reason: Ikaros recognizes a pentameric GGGAA core motif in cis-regulatory regions of Pol II-transcribed genes. This is its core DNA-binding function. The IBA from phylogenetic inference is consistent with extensive experimental evidence. Supporting Evidence: PMID:23071339 SYK phoshorylates Ikaros at unique C-terminal serine phosphorylation sites S358 and S361, thereby augmenting its nuclear localization and sequence-specific DNA binding activity
GO:0003677 DNA binding	IEA GO_REF:0000120	ACCEPT	Summary: IEA annotation for DNA binding. Ikaros is indeed a DNA-binding protein. This is broader than the IBA and IDA annotations for more specific DNA binding functions, but not incorrect. Reason: This is a valid broader IEA annotation. There are more specific IDA and IBA annotations (GO:0000978, GO:0003700) that capture the function more precisely, but the IEA at GO:0003677 is not wrong and is consistent with the more specific annotations.
GO:0005634 nucleus	IEA GO_REF:0000120	ACCEPT	Summary: IEA annotation for nuclear localization. Ikaros is a nuclear protein with experimentally verified nuclear localization by multiple studies. This IEA is well-supported. Reason: Nuclear localization of Ikaros is thoroughly established. There are also IDA annotations for nucleus (PMID:21548011, PMID:22106042) that provide direct experimental support. This IEA is consistent with the experimental evidence.
GO:0005737 cytoplasm	IEA GO_REF:0000044	ACCEPT	Summary: IEA annotation for cytoplasmic localization derived from UniProt subcellular location mapping. UniProt notes that isoform Ik6 localizes to the cytoplasm. The canonical full-length isoforms (Ik1, Ik2) are nuclear. This annotation appears to be based on isoform Ik6 behavior. Reason: While the canonical Ikaros isoforms are nuclear, the dominant-negative Ik6 isoform (lacking exons 4-7 and thus the DNA-binding zinc fingers) localizes to the cytoplasm. The IEA is derived from UniProt subcellular location which notes this. The annotation is technically correct but applies primarily to the Ik6 isoform.
GO:0006325 chromatin organization	IEA GO_REF:0000043	ACCEPT	Summary: IEA annotation from UniProt keyword mapping (Chromatin regulator). Ikaros recruits the NuRD chromatin remodeling complex and affects chromatin accessibility at target loci. This is well-supported by the biology. Reason: Ikaros is involved in chromatin organization through its recruitment of NuRD (CHD4/HDAC1/RBBP4) and BAF (SWI/SNF) chromatin remodeling complexes to target loci, causing changes in chromatin accessibility and histone modifications (loss of H3K27ac). The IEA keyword mapping is appropriate. Supporting Evidence: PMID:10204490 Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes
GO:0007498 mesoderm development	IEA GO_REF:0000117	MARK AS OVER ANNOTATED	Summary: IEA annotation from ARBA machine learning model. Hematopoietic cells are derived from mesoderm, so there is an indirect connection, but Ikaros is not a core regulator of mesoderm development per se. Its role is specifically in lymphoid and hematopoietic cell differentiation. Reason: While hematopoietic cells are mesodermal derivatives, annotating Ikaros to mesoderm development is over-annotation. Ikaros functions specifically in hematopoietic and lymphoid lineage commitment and differentiation, not in broad mesoderm specification. The ARBA model likely inferred this from the association of lymphoid development with mesodermal lineage, but the annotation is too general and misleading for Ikaros's actual role.
GO:0008270 zinc ion binding	IEA GO_REF:0000043	ACCEPT	Summary: IEA from UniProt keyword mapping. Ikaros has six C2H2-type zinc fingers that coordinate zinc ions. This is structurally accurate. Reason: Ikaros contains six C2H2-type zinc finger domains (four N-terminal for DNA binding, two C-terminal for dimerization), each of which coordinates a zinc ion. This is a well-established structural feature confirmed by X-ray crystallography and cryo-EM structures (PDB: 6H0F, 8D7Z, 8RQC, 8TNQ).
GO:0030098 lymphocyte differentiation	IEA GO_REF:0000117	ACCEPT	Summary: IEA from ARBA model for lymphocyte differentiation. Ikaros is essential for lymphocyte differentiation, particularly B and T cell lineage commitment. This is a core function of Ikaros. There is also an IMP annotation for this term. Reason: Lymphocyte differentiation is the most fundamental biological process role of Ikaros. This IEA is consistent with extensive experimental evidence and the IMP annotation from PMID:17934067. Ikaros is absolutely required for B and T cell development.
GO:0046872 metal ion binding	IEA GO_REF:0000043	ACCEPT	Summary: IEA from UniProt keyword mapping (Metal-binding). This is a parent term of zinc ion binding (GO:0008270) and is redundant but not incorrect. Reason: This is a broader parent of the more specific zinc ion binding annotation. It is technically correct given the zinc finger domains, though less informative than GO:0008270.
GO:0005515 protein binding	IPI PMID:21516116 Next-generation sequencing to generate interactome datasets	MARK AS OVER ANNOTATED	Summary: IPI annotation from a high-throughput next-generation sequencing interactome study (Stelzl lab). The interactions include CTBP2, RAD51D, and others detected by Y2H. Reason: 'Protein binding' (GO:0005515) is uninformative and does not tell us about the actual molecular function. High-throughput Y2H studies can detect many interactions, some of which may not be physiologically relevant. Some of the detected interactors (e.g., CTBP2) are relevant to Ikaros transcriptional repression function (CtBP is a known co-repressor partner), but the generic 'protein binding' annotation does not capture this. Where specific interactions are functionally validated, more specific terms should be used.
GO:0005515 protein binding	IPI PMID:25416956 A proteome-scale map of the human interactome network	MARK AS OVER ANNOTATED	Summary: IPI annotation from a large-scale proteome-wide interactome mapping study (Rolland et al., 2014). This study detected many interactors including MTA1, CTBP1, CTBP2 (co-repressor complex partners), PIN1, and others. Some of these interactions are physiologically relevant (MTA1 is a NuRD component, CtBP1/2 are known Ikaros co-repressors). Reason: As with the previous protein binding annotation, GO:0005515 is uninformative. While some of the interactors (MTA1, CTBP1, CTBP2) validate known Ikaros functions in the NuRD complex and co-repressor recruitment, the generic protein binding term does not capture these meaningful interactions. High-throughput studies inherently include false positives.
GO:0005515 protein binding	IPI PMID:29892012 An interactome perturbation framework prioritizes damaging m...	MARK AS OVER ANNOTATED	Summary: IPI annotation from a study on interactome perturbation by missense mutations in developmental disorders (Sahni et al., 2015). Reason: Generic protein binding annotation from a high-throughput perturbation study. GO:0005515 is uninformative about the actual function of Ikaros.
GO:0005515 protein binding	IPI PMID:31515488 Extensive disruption of protein interactions by genetic vari...	MARK AS OVER ANNOTATED	Summary: IPI annotation from a study on disruption of protein interactions by genetic variants across allele frequency spectrum. Reason: Generic protein binding annotation from high-throughput study. GO:0005515 does not add informative functional annotation for Ikaros.
GO:0005515 protein binding	IPI PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling...	MARK AS OVER ANNOTATED	Summary: IPI from a dual proteome-scale network study (Huttlin et al., 2021). Detected interactors include CTBP2, MTA1, WTAP, and MCRS1. MTA1 is a validated NuRD subunit. Reason: Generic protein binding annotation from high-throughput study. While MTA1 and CTBP2 interactions validate known Ikaros biology, GO:0005515 is too general.
GO:0005515 protein binding	IPI PMID:39251607 Systematic identification of post-transcriptional regulatory...	MARK AS OVER ANNOTATED	Summary: IPI from a systematic post-transcriptional regulatory module study. The interactor is DDX6 (P26196). Reason: Generic protein binding annotation. DDX6 interaction with Ikaros lacks clear functional significance in the context of Ikaros's known transcriptional regulatory roles.
GO:0005515 protein binding	IPI PMID:40205054 Multimodal cell maps as a foundation for structural and func...	MARK AS OVER ANNOTATED	Summary: IPI from a multimodal cell maps study (Hein et al., 2024). Detected interactor is CTBP2. Reason: Generic protein binding annotation. While CTBP2 is a validated co-repressor partner of Ikaros, GO:0005515 does not capture this functional significance.
GO:0005654 nucleoplasm	IDA GO_REF:0000052	ACCEPT	Summary: IDA annotation based on immunofluorescence data from the Human Protein Atlas (HPA). Ikaros is detected in the nucleoplasm, consistent with its role as a nuclear transcription factor. Reason: Nucleoplasmic localization is consistent with Ikaros's function as a DNA-binding transcription factor. In resting lymphocytes, Ikaros is distributed diffusely throughout the nucleus (nucleoplasm), while in proliferating cells it concentrates at pericentromeric heterochromatin. The HPA immunofluorescence data support this nucleoplasmic localization.
GO:0005515 protein binding	IPI PMID:15491138 Structural studies on a protein-binding zinc-finger domain o...	MARK AS OVER ANNOTATED	Summary: IPI annotation for protein binding based on interaction with IQSEC2 (Q9H2S9). This is from a CAFA-curated annotation. The interaction was detected by protein-protein interaction assay. Reason: Generic protein binding annotation. The interaction with IQSEC2 does not have clear functional relevance to Ikaros's known transcriptional regulatory role. GO:0005515 is uninformative.
GO:0032991 protein-containing complex	IDA PMID:23071339 Serine phosphorylation by SYK is critical for nuclear locali...	MODIFY	Summary: IDA annotation indicating Ikaros is part of a protein-containing complex, curated by MGI based on the Uckun et al. (2012) study on SYK phosphorylation of Ikaros. The study demonstrates Ikaros exists in protein complexes (with SYK, and as part of larger complexes in the nucleus). Reason: While Ikaros is indeed part of protein complexes, GO:0032991 is extremely generic. The most well-characterized complex containing Ikaros is the NuRD complex (GO:0016581), which includes CHD4, HDAC1, HDAC2, RBBP4, RBBP7, MTA1/2, MBD2/3. Ikaros directly interacts with CHD4 within the NuRD complex. A more specific annotation to NuRD complex would be more informative. Proposed replacements: NuRD complex Supporting Evidence: PMID:10204490 Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes [Ikaros is a component of the NuRD complex] PMID:23071339 Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros
GO:0019904 protein domain specific binding	IPI PMID:15491138 Structural studies on a protein-binding zinc-finger domain o...	UNDECIDED	Summary: IPI annotation for protein domain specific binding, curated by CAFA. The interactor is IQSEC2 (Q9H2S9). This indicates that the Ikaros interaction with IQSEC2 involves a specific domain. Reason: The publication PMID:15491138 is not available in the publications cache so the details of the IQSEC2 interaction cannot be verified. IQSEC2 is a guanine nucleotide exchange factor for ARF GTPases and its functional relationship to Ikaros's transcriptional function is unclear.
GO:0032991 protein-containing complex	IMP PMID:15491138 Structural studies on a protein-binding zinc-finger domain o...	MODIFY	Summary: IMP annotation indicating Ikaros is part of a protein-containing complex, curated by CAFA from PMID:15491138. Mutant phenotype evidence for complex membership. Reason: As with the IDA annotation for GO:0032991, this term is too generic. Ikaros is a well-characterized component of the NuRD complex. The more specific term GO:0016581 (NuRD complex) should be used. Proposed replacements: NuRD complex
GO:0003677 DNA binding	IDA PMID:21548011 Congenital pancytopenia and absence of B lymphocytes in a ne...	ACCEPT	Summary: IDA annotation for DNA binding from Goldman et al. (2012), which studied a CVID13-causing mutation (Y210C) in IKZF1 and characterized wild-type vs. mutant DNA binding. The study confirmed that wild-type Ikaros binds DNA. Reason: DNA binding is a core molecular function of Ikaros, mediated by its N-terminal C2H2 zinc fingers. This IDA from PMID:21548011 provides direct experimental evidence. There are also more specific annotations (GO:0000978) that better describe the DNA-binding specificity.
GO:0005634 nucleus	IDA PMID:21548011 Congenital pancytopenia and absence of B lymphocytes in a ne...	ACCEPT	Summary: IDA annotation for nuclear localization from Goldman et al. (2012). The study demonstrated that wild-type Ikaros localizes to the nucleus, while the Y210C mutant shows diffuse nuclear localization (loss of pericentromeric foci). Reason: Nuclear localization is essential for Ikaros transcription factor function. The IDA from PMID:21548011 provides direct experimental evidence via confocal microscopy. Supporting Evidence: PMID:23071339 SYK-induced Ikaros activation is essential for its nuclear localization and optimal transcription factor function
GO:0005721 pericentric heterochromatin	IDA PMID:21548011 Congenital pancytopenia and absence of B lymphocytes in a ne...	ACCEPT	Summary: IDA annotation for pericentric heterochromatin localization from Goldman et al. (2012). Ikaros forms characteristic punctate foci at pericentromeric heterochromatin in proliferating lymphocytes. The Y210C mutant disrupts this localization. Reason: Pericentromeric heterochromatin localization is a distinctive and functionally important feature of Ikaros biology. In proliferating lymphocytes, Ikaros forms bright punctate foci at pericentromeric heterochromatin, which is thought to be important for gene silencing and heterochromatin maintenance. This localization requires intact zinc fingers 2 and 3.
GO:0003677 DNA binding	IDA PMID:22106042 Cell cycle-specific function of Ikaros in human leukemia	ACCEPT	Summary: IDA annotation for DNA binding from Li et al. (2012), which studied cell cycle-specific function of Ikaros in human leukemia. The study demonstrated that Ikaros DNA-binding ability varies through the cell cycle, with phosphorylation reducing DNA binding. Reason: This IDA provides additional experimental evidence for Ikaros DNA binding, with the important finding that DNA binding is cell-cycle regulated by phosphorylation.
GO:0005634 nucleus	IDA PMID:22106042 Cell cycle-specific function of Ikaros in human leukemia	ACCEPT	Summary: IDA annotation for nuclear localization from Li et al. (2012). The study showed that Ikaros nuclear localization varies through the cell cycle. Reason: Provides direct experimental evidence for nuclear localization. Consistent with other nucleus annotations.
GO:0030098 lymphocyte differentiation	IMP PMID:17934067 The role of Ikaros in human erythroid differentiation	ACCEPT	Summary: IMP annotation for lymphocyte differentiation from Dijon et al. (2008), which studied the role of Ikaros in human erythroid differentiation. The study used Ikaros isoform manipulation to demonstrate effects on differentiation of hematopoietic progenitors, including lymphoid lineages. Reason: Lymphocyte differentiation is a core biological process for Ikaros. Ikaros is absolutely required for B and T cell development. The IMP from PMID:17934067 provides human experimental evidence. Mouse knockouts completely lack lymphoid lineages, and human haploinsufficiency (CVID13) causes B cell deficiency. Supporting Evidence: PMID:23071339 Ikaros is a zinc finger-containing DNA-binding protein that plays a pivotal role in immune homeostasis through transcriptional regulation of the earliest stages of lymphocyte ontogeny and differentiation
GO:0030218 erythrocyte differentiation	IMP PMID:17934067 The role of Ikaros in human erythroid differentiation	KEEP AS NON CORE	Summary: IMP annotation for erythrocyte differentiation from Dijon et al. (2008), titled "The role of Ikaros in human erythroid differentiation." The study demonstrated that Ikaros modulates erythroid differentiation of human hematopoietic progenitors. Reason: While Ikaros's primary role is in lymphocyte development, the Dijon et al. study provided evidence that Ikaros also plays a role in erythroid differentiation. UniProt notes that Ikaros "increases normal apoptosis in adult erythroid cells" and "targets NuRD and BAF complexes to the beta-globin locus in adult erythrocytes." This is a secondary, non-core function compared to the primary role in lymphopoiesis.
GO:0045892 negative regulation of DNA-templated transcription	ISS GO_REF:0000024	ACCEPT	Summary: ISS annotation from manual transfer of experimentally verified annotation from mouse ortholog (Q03267). Ikaros is well-established as a transcriptional repressor that recruits NuRD complex to target genes, causing loss of enhancer H3K27ac and chromatin accessibility. Reason: Transcriptional repression is the primary mode of action of Ikaros. Recent studies (Zhang et al., Blood 2025) have mapped conserved helical motifs in the Ikaros intrinsically disordered region that bind RBBP4 in NuRD, and time-resolved analyses show that downregulation of target transcripts precedes any activation events upon Ikaros induction. The ISS annotation based on mouse ortholog data is well-supported. Supporting Evidence: PMID:10204490 Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes [forms NuRD repressor complex]
GO:0003677 DNA binding	TAS PMID:8543809 The Ikaros gene encodes a family of lymphocyte-restricted zi...	ACCEPT	Summary: TAS annotation for DNA binding from Molnar et al. (1996), the original characterization of the human Ikaros gene. This seminal paper established Ikaros as a family of lymphocyte-restricted zinc finger DNA binding proteins. Reason: This is the foundational publication establishing Ikaros as a DNA-binding protein. While there are now more specific annotations, this TAS annotation reflects established knowledge that remains accurate. Supporting Evidence: PMID:8543809 The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse
GO:0007498 mesoderm development	TAS PMID:8543809 The Ikaros gene encodes a family of lymphocyte-restricted zi...	MARK AS OVER ANNOTATED	Summary: TAS annotation for mesoderm development from Molnar et al. (1996). This early annotation likely reflected the connection between lymphoid development and mesodermal origin of hematopoietic cells. Reason: As with the IEA annotation for the same term, this is an over-annotation. Ikaros is specifically involved in hematopoietic/lymphoid differentiation, not in mesoderm development broadly. The original paper (Molnar et al., 1996) characterized Ikaros as a lymphoid transcription factor, not as a mesoderm regulator. The TAS annotation appears to have been applied too broadly.
GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific	ISS PMID:10204490 Ikaros DNA-binding proteins direct formation of chromatin re...	NEW	Summary: Ikaros predominantly functions as a transcriptional repressor. It recruits the NuRD chromatin remodeling/HDAC complex to target gene enhancers, causing rapid loss of chromatin accessibility and H3K27ac. Recent work (Zhang et al., Blood 2025) mapped the conserved helical motifs in the Ikaros disordered region that mediate NuRD binding. Time-resolved analyses show that repression (downregulation of targets, loss of H3K27ac) is the immediate dominant response upon Ikaros induction, preceding any activation events. This is the most specific and informative MF term for Ikaros's primary transcriptional activity, as recommended by the GO TF annotation guidelines. Reason: Per GO transcription factor annotation guidelines, the recommended MF annotation for a DNA-binding transcription factor is a child of GO:0000981 (RNA polymerase II-specific). Since Ikaros predominantly acts as a repressor via NuRD recruitment, GO:0001227 is the most accurate term. This is not currently annotated in the GOA dataset but is strongly supported by the literature. Supporting Evidence: PMID:10204490 Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes [Ikaros recruits NuRD repressor complex] PMID:23071339 Ikaros is a zinc finger-containing DNA-binding protein that plays a pivotal role in immune homeostasis through transcriptional regulation
GO:0016581 NuRD complex	IDA PMID:10204490 Ikaros DNA-binding proteins direct formation of chromatin re...	NEW	Summary: Ikaros is a well-characterized component of the NuRD chromatin remodeling complex in lymphocytes. Kim et al. (1999) identified Ikaros in the NuRD complex and showed it interacts directly with CHD4. The NuRD complex containing Ikaros includes CHD4, HDAC1, HDAC2, RBBP4, RBBP7, MTA1/2, MBD2/3. This complex association is central to Ikaros's transcriptional repressor function. Reason: The existing annotations use the generic GO:0032991 (protein-containing complex). Ikaros's membership in the NuRD complex is its best-characterized complex association and is central to its function. This specific CC annotation should be added. Supporting Evidence: PMID:10204490 Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes
GO:0042802 identical protein binding	IPI PMID:8543809 The Ikaros gene encodes a family of lymphocyte-restricted zi...	NEW	Summary: Ikaros forms homodimers via its C-terminal zinc fingers (F5-F6). This homodimerization is a well-established feature of Ikaros biology, documented in the original characterization papers and confirmed by subsequent structural and biochemical studies. The GOA dataset from IntAct includes the self-interaction (Q13422-7 with Q13422-7). This is functionally important as dimerization modulates transcriptional activity. Reason: Ikaros homodimerization via C-terminal zinc fingers is well-established and functionally important. This is more informative than generic GO:0005515 (protein binding) for capturing the self-interaction.
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific	IBA GO_REF:0000033	NEW	Summary: Ikaros functions as a DNA-binding transcription factor that regulates RNA polymerase II transcription. It can both repress (primarily) and activate transcription depending on context and target gene. The deep research review (IKZF1-deep-research-falcon.md) details that Ikaros directly regulates Pol II transcription at target genes including IL7R, FLT3, NOTCH1, RAG1, DNTT, and HDAC9. Reason: This Pol II-specific transcription factor activity term is used in core_functions to describe the broader transcription factor role of Ikaros (complementing the more specific repressor term GO:0001227). While GO:0003700 (the parent term) is present as an IBA, this more specific child term better captures that Ikaros targets are Pol II-transcribed genes. Supporting Evidence: PMID:10204490 Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes
GO:0030183 B cell differentiation	IMP PMID:26981933 Loss of B Cells in Patients with Heterozygous Mutations in I...	NEW	Summary: Ikaros is essential for B cell differentiation. Patients with heterozygous IKZF1 mutations (R162Q, R162L, H167R, R184Q) that abolish DNA binding show near-complete absence of B cells (Kuehn et al., 2016). The deep research review (IKZF1-deep-research-falcon.md) details that Ikaros-null mice lack all B cells, and haploinsufficient patients have dramatically reduced B cell counts. B cell differentiation is a more specific child of lymphocyte differentiation (GO:0030098) that more precisely captures Ikaros's most striking phenotype. Reason: While lymphocyte differentiation (GO:0030098) is already annotated, B cell differentiation (GO:0030183) specifically captures the most prominent phenotype of IKZF1 loss-of-function in both mice and humans. This specificity is warranted given the dramatic B cell deficiency phenotype. Supporting Evidence: PMID:26981933 Heterozygous mutations in the transcription factor IKAROS caused an autosomal dominant form of CVID that is associated with a striking decrease in B-cell numbers PMID:21548011 Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene

Core Functions

Ikaros binds a/gGGAA DNA motifs in cis-regulatory regions of target genes and predominantly represses their transcription by recruiting the NuRD chromatin remodeling complex (CHD4/RBBP4/HDAC1), causing rapid loss of enhancer H3K27ac and chromatin accessibility. This is the primary molecular function of Ikaros.

Molecular Function:

DNA-binding transcription repressor activity, RNA polymerase II-specific

Directly Involved In:

negative regulation of DNA-templated transcription chromatin organization

Cellular Locations:

nucleus

In Complex:

NuRD complex

Supporting Evidence:

PMID:10204490
Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes
PMID:23071339
Ikaros is a zinc finger-containing DNA-binding protein that plays a pivotal role in immune homeostasis through transcriptional regulation

Ikaros is essential for B cell and T cell lineage commitment and differentiation from hematopoietic progenitors. Mouse knockouts completely lack lymphoid lineages, and human haploinsufficiency (IKZF1 heterozygous mutations causing CVID13) results in a striking decrease in B cell numbers. This is the primary biological process role.

Molecular Function:

DNA-binding transcription factor activity, RNA polymerase II-specific

Directly Involved In:

lymphocyte differentiation B cell differentiation

Cellular Locations:

nucleus

Supporting Evidence:

PMID:17934067
The role of Ikaros in human erythroid differentiation [study also demonstrated lymphocyte differentiation role]
PMID:21548011
Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene

In proliferating lymphocytes, Ikaros localizes to pericentromeric heterochromatin, forming characteristic punctate foci visible by immunofluorescence. This localization requires DNA binding via zinc fingers 2 and 3 and is regulated by phosphorylation/dephosphorylation. Ikaros also associates with the BAF (SWI/SNF) complex via SMARCA4.

Molecular Function:

RNA polymerase II cis-regulatory region sequence-specific DNA binding

Directly Involved In:

regulation of transcription by RNA polymerase II

Cellular Locations:

pericentric heterochromatin nucleoplasm

Supporting Evidence:

PMID:21548011
Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene

References

GO_REF:0000024

Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity

GO_REF:0000033

Annotation inferences using phylogenetic trees

GO_REF:0000043

Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping

GO_REF:0000044

Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt

GO_REF:0000052

Gene Ontology annotation based on curation of immunofluorescence data

GO_REF:0000117

Electronic Gene Ontology annotations created by ARBA machine learning models

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

PMID:8543809

The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse

Established Ikaros as a family of lymphocyte-restricted zinc finger DNA binding proteins in human and mouse, with multiple alternatively spliced isoforms

"differential splicing of Ikaros primary transcripts generates a family of lymphoid-restricted zinc finger DNA binding proteins, highly conserved in sequence composition and relative expression to the mouse homologues. Expression of Ikaros isoforms is highly restricted to the lymphopoietic system and is particularly enriched in maturing thymocytes."

PMID:8964602

Cloning and sequencing of hIk-1, a cDNA encoding a human homologue of mouse Ikaros/LyF-1

PMID:10204490

Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes

Identified Ikaros as a component of the NuRD chromatin remodeling complex and showed direct interaction with CHD4 and SMARCA4, demonstrating Ikaros targets both NuRD and BAF complexes in lymphocytes

"a major fraction of Ikaros and Aiolos proteins associate with the DNA-dependent ATPase Mi-2 and histone deacetylases, in a 2 MD complex. This Ikaros-NURD complex is active in chromatin remodeling and histone deacetylation. Upon T cell activation, Ikaros recruits Mi-2/HDAC to regions of heterochromatin."

PMID:10978333

Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities

Characterized IKZF4 (Eos) and IKZF5 (Pegasus) interactions with IKZF1 (Ikaros), demonstrating heterodimerization between Ikaros family members

"Pegasus self-associates and binds to other family members but recognizes distinct DNA-binding sites. Eos and Pegasus repress the expression of reporter genes containing their recognition elements. Our results suggest that these proteins may associate with previously described Ikaros family proteins in lymphoid cells"

PMID:15491138

Structural studies on a protein-binding zinc-finger domain of Eos reveal both similarities and differences to classical zinc fingers.

PMID:17135265

Human Ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms

Demonstrated that Ikaros function in human T cells depends on coordinated expression of different isoforms, with dominant-negative isoforms modulating activity; confirmed subcellular localization and gamma-satellite DNA binding

"the DNA binding affinity of hIK-H differs from that of hIK-VI. Co-expression of hIk-H with hIk-VI alters the ability of Ikaros complexes to bind DNA motifs found in pericentromeric heterochromatin (PC-HC). In the nucleus, hIK-VI is localized solely in PC-HC, whereas the hIK-H protein exhibits dual centromeric and non-centromeric localization."

PMID:17934067

The role of Ikaros in human erythroid differentiation

Demonstrated that Ikaros plays a role in human erythroid differentiation and lymphocyte differentiation, using isoform manipulation of hematopoietic progenitors

"Ikaros is involved in human adult or fetal erythroid differentiation as well as in the commitment between erythroid and myeloid cells"

PMID:19141594

Human gamma-satellite DNA maintains open chromatin structure and protects a transgene from epigenetic silencing

Demonstrated Ikaros binding to gamma-satellite DNA at pericentromeric heterochromatin

"These arrays contain CTCF and Ikaros binding sites. In MEL cells, this gamma-satellite DNA activity depends on binding of Ikaros proteins involved in differentiation along the hematopoietic pathway."

PMID:21516116

Next-generation sequencing to generate interactome datasets

PMID:21548011

Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene

Identified IKZF1 Y210C mutation causing CVID13, characterized DNA binding defect and loss of pericentromeric heterochromatin localization in the mutant

"DNA studies revealed a point mutation in one allele of the IKAROS gene, resulting in an amino acid substitution in the DNA-binding zinc finger domain. Functional studies demonstrated that the observed mutation decreased Ikaros DNA-binding affinity, and immunofluorescence microscopy revealed aberrant Ikaros pericentromeric localization."

PMID:22106042

Cell cycle-specific function of Ikaros in human leukemia

Demonstrated cell cycle-dependent DNA binding and nuclear localization of Ikaros, with phosphorylation regulating these properties

"RESULTS: The DNA-binding activity of human Ikaros complexes undergoes dynamic changes as the cell cycle progresses"

PMID:23071339

Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros

SYK phosphorylates Ikaros at S361 and S364, augmenting nuclear localization and sequence-specific DNA binding activity. SYK-induced Ikaros activation is essential for nuclear localization and optimal transcription factor function.

"SYK phoshorylates Ikaros at unique C-terminal serine phosphorylation sites S358 and S361, thereby augmenting its nuclear localization and sequence-specific DNA binding activity"

PMID:25416956

A proteome-scale map of the human interactome network

PMID:26981933

Loss of B Cells in Patients with Heterozygous Mutations in IKAROS

Identified multiple IKZF1 mutations (R162Q, R162L, H167R, R184Q) in CVID13 patients that abolish DNA binding, demonstrating essential role of zinc finger domain integrity for Ikaros function

"Heterozygous mutations in the transcription factor IKAROS caused an autosomal dominant form of CVID that is associated with a striking decrease in B-cell numbers"

PMID:29892012

An interactome perturbation framework prioritizes damaging missense mutations for developmental disorders

PMID:31515488

Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations

PMID:33961781

Dual proteome-scale networks reveal cell-specific remodeling of the human interactome

PMID:39251607

Systematic identification of post-transcriptional regulatory modules

PMID:40205054

Multimodal cell maps as a foundation for structural and functional genomics

Deep Research

Falcon

(IKZF1-deep-research-falcon.md)

this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 27 citations 2026-02-14T14:28:59.850275

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research plan and verification
- Identity check: IKZF1 (UniProt Q13422) encodes the human DNA-binding protein Ikaros, a lymphoid-restricted C2H2-type zinc-finger transcription factor. Literature consistently places IKZF1/Ikaros in the Ikaros family of C2H2 zinc-finger proteins, with N-terminal DNA-binding zinc fingers and C-terminal dimerization zinc fingers, matching the UniProt description and domain architecture. These features and its role in lymphopoiesis confirm we are working on the correct human gene/protein (Homo sapiens). (https://doi.org/10.3390/biomedicines12010089, Jan 2024) (paolino2024ikzf1alterationsand pages 2-4)

1) Key concepts and definitions with current understanding
- Molecular identity, domains, and isoforms: IKZF1/Ikaros contains four N-terminal Krüppel-like C2H2 zinc fingers (F1–F4) for DNA binding and two C-terminal zinc fingers (F5–F6) that mediate homo/heterodimerization and protein interactions. Alternative splicing yields ≥16 isoforms; IK1–IK3 retain ≥3 N-terminal fingers and bind DNA, whereas shorter isoforms (e.g., IK6 from deletion of exons 4–7) lack sufficient N-terminal fingers to bind DNA but retain C-terminal fingers for dimerization, acting as dominant negatives. (https://doi.org/10.3390/biomedicines12010089, Jan 2024) (paolino2024ikzf1alterationsand pages 2-4, paolino2024ikzf1alterationsand pages 1-2)
- DNA-binding motif: Ikaros recognizes a pentameric GGGAA core motif (often represented a/gGGAA), bound by its N‑terminal zinc fingers. (https://doi.org/10.3390/biomedicines12010089, Jan 2024) (paolino2024ikzf1alterationsand pages 1-2)
- Cellular localization and dimerization: Ikaros localizes to the nucleus with enrichment at pericentromeric heterochromatin in lymphocytes during interphase and forms homo- and heterodimers (e.g., with IKZF3/Aiolos) via C‑terminal zinc fingers. (preprint; https://doi.org/10.1101/2024.04.23.590758, Apr 2025) (dimond2025pbktopkmediatesikaros pages 1-5)
- Principal mechanism of action: Ikaros predominantly acts as a transcriptional repressor by recruiting the NuRD chromatin-remodeling/HDAC complex (CHD4/RBBP4/HDAC1). Rapid, direct repression follows Ikaros binding, with focal loss of chromatin accessibility and H3K27ac at enhancers; co-repressor partners include CtBP1 and KAP1, with additional heterochromatin-associated factors (DNMT1, UHRF1, HP1). (preprint; https://doi.org/10.1101/2024.02.29.582782, Feb 2024; and peer-reviewed update https://doi.org/10.1182/blood.2024024787, Jan 2025) (zhang2024conservedhelicalmotifs pages 3-6, zhang2024conservedhelicalmotifs pages 1-3, zhang2025conservedhelicalmotifs pages 27-28, zhang2025conservedhelicalmotifs pages 10-12)

2) Recent developments and latest research (priority 2023–2024)
- NuRD interaction mechanism resolved: New work mapped conserved helical motifs in the intrinsically disordered region of IKZF1 that bind RBBP4 in NuRD; mutation of key KRK residues disrupts NuRD recruitment and transcriptional repression in pre‑B cells. (https://doi.org/10.1182/blood.2024024787, Jan 2025; preprint Feb 2024) (zhang2025conservedhelicalmotifs pages 27-28, zhang2025conservedhelicalmotifs pages 10-12, zhang2024conservedhelicalmotifs pages 3-6, zhang2024conservedhelicalmotifs pages 1-3)
- Immediate repression dominates early Ikaros response: Time-resolved analyses show that upon Ikaros induction, downregulation of target transcripts and loss of local chromatin accessibility/H3K27ac at enhancers precede any activation events, clarifying the temporal sequence of Ikaros function. (preprint; https://doi.org/10.1101/2024.02.29.582782, Feb 2024) (zhang2024conservedhelicalmotifs pages 3-6, zhang2024conservedhelicalmotifs pages 1-3)
- Mitosis-specific regulation: PBK/TOPK kinase phosphorylates Ikaros (and other C2H2-ZFs) to evict it from mitotic chromosomes; inhibition (OTS514) reverses eviction, revealing dynamic kinase–phosphatase control of mitotic chromatin association. (preprint; https://doi.org/10.1101/2024.04.23.590758, Apr 2025) (dimond2025pbktopkmediatesikaros pages 12-14, dimond2025pbktopkmediatesikaros pages 1-5)
- CK2-linked modulation: Phosphorylation reduces Ikaros DNA binding; CK2 and other modifiers have been implicated among top interactors in pre‑B cells, consistent with classical regulation of Ikaros by CK2/PP1. (preprint; https://doi.org/10.1101/2024.02.29.582782, Feb 2024; review https://doi.org/10.3390/biomedicines12010089, Jan 2024) (zhang2024conservedhelicalmotifs pages 1-3, paolino2024ikzf1alterationsand pages 1-2)

3) Function, biological processes, localization, and pathways
- Lineage specification and lymphoid development: Ikaros primes hematopoietic stem/progenitor cells toward lymphoid fates and is essential for B‑ and T‑cell development; mouse deletions of N‑terminal zinc fingers or exon 5 block lymphoid differentiation. (https://doi.org/10.3390/biomedicines12010089, Jan 2024) (paolino2024ikzf1alterationsand pages 2-4)
- Gene programs under Ikaros control: Ikaros regulates genes involved in chromatin/transcription (e.g., HDAC9), signaling (e.g., IL7R, FLT3, NOTCH1), and antigen receptor development (e.g., RAG1, DNTT), consistent with a central role in B‑cell lineage programming. (https://doi.org/10.3390/biomedicines12010089, Jan 2024) (paolino2024ikzf1alterationsand pages 2-4)
- Subcellular context: Nuclear and pericentromeric heterochromatin localization in lymphocytes, dimerization via C‑terminal ZFs, and NuRD-dependent repression at enhancers clarify where and how Ikaros executes its function. (preprint; https://doi.org/10.1101/2024.04.23.590758, Apr 2025; preprint and peer-reviewed https://doi.org/10.1101/2024.02.29.582782; https://doi.org/10.1182/blood.2024024787) (dimond2025pbktopkmediatesikaros pages 1-5, zhang2024conservedhelicalmotifs pages 3-6, zhang2025conservedhelicalmotifs pages 27-28, zhang2025conservedhelicalmotifs pages 10-12)

4) Clinical relevance: alterations, biomarkers, and outcomes in B‑ALL
- Spectrum and frequencies of IKZF1 alterations: IKZF1 deletions are found in ≈15% of Ph‑negative pediatric B‑ALL overall (up to ≈30% in NCI high‑risk Ph‑negative cohorts), ≈70% in BCR::ABL1-positive (Ph+) ALL, and up to ≈68% in Ph‑like ALL; point mutations (≈2% in high‑risk pediatric cohorts) and rare fusions occur but are less common. (https://doi.org/10.3390/biomedicines12010089, Jan 2024) (paolino2024ikzf1alterationsand pages 4-6, paolino2024ikzf1alterationsand pages 6-7)
- Dominant-negative isoform IK6: The hallmark intragenic deletion of exons 4–7 generates IK6, a non‑DNA‑binding dominant negative that suppresses wild-type IKZF1 and family members. (https://doi.org/10.3390/biomedicines12010089, Jan 2024) (paolino2024ikzf1alterationsand pages 2-4)
- IKZF1plus biomarker: IKZF1plus is defined as an IKZF1 deletion coexisting with deletions of PAX5, CDKN2A/2B, or the PAR1 region, in the absence of ERG deletion. In AIEOP‑BFM ALL 2000, IKZF1plus occurred in ~6% and conferred adverse outcomes (5‑yr EFS 53% vs 79% for IKZF1del alone and 87% for IKZF1‑intact; 5‑yr relapse incidence 44% vs 11%). (https://doi.org/10.3390/biomedicines12010089, Jan 2024) (paolino2024ikzf1alterationsand pages 6-7)
- Population disparities and higher prevalence in specific settings: Hispanic/Latino children show enrichment of high‑risk features; IKZF1 deletions have been reported at ~30% vs 13% in non‑H/L cohorts and IKZF1plus contributes to outcome disparities. (https://doi.org/10.1002/pbc.30996, Apr 2024) (kovach2024ikzf1plusalterationscontribute pages 10-14)
- Country-specific prevalence and outcomes: In an unselected Mexican pediatric B‑ALL cohort (NGS detection), IKZF1plus frequency was 21.8%, associated with older age, enrichment in high‑risk classification, and reduced 5‑yr OS; IK6 (exons 4–7 loss) and whole‑gene deletions were the most common IKZF1 events. (https://doi.org/10.3389/fonc.2024.1337954, Apr 2024) (garciasolorio2024ikzf1plusisa pages 6-9)
- Prognostic impact across subtypes: IKZF1 deletions associate with inferior EFS/DFS in Ph+ ALL (pre‑ and post‑TKI eras) and in Ph‑like ALL (children: 5‑yr EFS 48% vs 72%; young adults: 19% vs 43%). Even in favorable subtypes (ETV6::RUNX1, high hyperdiploidy), IKZF1 deletions, when present, reduce EFS. (https://doi.org/10.3390/biomedicines12010089, Jan 2024) (paolino2024ikzf1alterationsand pages 6-7)

5) Therapeutic applications and real-world implementations
- Cereblon-recruiting degraders (IMiDs and CELMoDs): Thalidomide analogs and next‑generation CELMoDs act as molecular glues to recruit CRBN (CRL4^CRBN), triggering proteasomal degradation of IKZF1/IKZF3, which downregulates IRF4 and MYC programs and augments T/NK cell activation. (https://doi.org/10.3389/fonc.2024.1512666, Dec 2024) (hu2024moleculargluedegrader pages 2-4)
- Agents and clinical progression (2023–2024 emphasis): Lenalidomide and pomalidomide remain standards; next‑generation CELMoDs (iberdomide CC‑220, mezigdomide CC‑92480) bind CRBN with 10–20× higher affinity than IMiDs and induce more profound/faster IKZF1/3 degradation, showing activity in IMiD‑refractory multiple myeloma (e.g., ORR ~26% for iberdomide and ~40% for mezigdomide in early studies). Trial activity includes phase 1/2/3 studies (e.g., NCT02773030, NCT04975997, NCT03989414). (https://doi.org/10.3324/haematol.2024.285636, Nov 2024; https://doi.org/10.3389/fonc.2024.1512666, Dec 2024) (teoh2024resistancetoimmunomodulatory pages 14-15, hu2024moleculargluedegrader pages 10-11)
- Broader hematology/oncology landscape: Reviews highlight ongoing development of CRBN-based molecular glues and CELMoDs across hematologic malignancies (including NHL), with multiple agents advancing clinically and efforts to improve selectivity and overcome resistance. (https://doi.org/10.3389/fonc.2024.1512666, Dec 2024) (hu2024moleculargluedegrader pages 10-11)

6) Resistance and expert analyses
- CRBN-dependent and CRBN-independent resistance: Resistance to IMiDs/CELMoDs can arise from alterations along the CRBN–IKZF1/3 axis and from parallel adaptive mechanisms. Documented non‑CRBN pathways include Wnt/β‑catenin/CD44 upregulation (adhesion-mediated resistance), MEK/ERK activation (e.g., RAS/RAF mutations; re-sensitization by MEK inhibitors in models), TRAF2 modulation, metabolic changes (elevated lactate), extracellular vesicle signaling (SORT1/LAMP2), and immune dysfunction (T‑cell exhaustion, decreased TCR diversity). Compensatory transcription factors (e.g., BATF, ETV4) can sustain IRF4/MYC despite IKZF1/3 loss. (https://doi.org/10.3324/haematol.2024.285636, Nov 2024) (teoh2024resistancetoimmunomodulatory pages 7-9, teoh2024resistancetoimmunomodulatory pages 6-7)
- Next‑generation strategies: Reviews propose using more potent CELMoDs (iberdomide/mezigdomide), rational combinations, and integrative CRISPR/single‑cell profiling to tackle multi‑factorial resistance in the tumor and microenvironment. (https://doi.org/10.3324/haematol.2024.285636, Nov 2024) (teoh2024resistancetoimmunomodulatory pages 14-15)

7) Quantitative data highlights (frequencies, outcomes)
- IKZF1 deletion frequencies: ≈15% in pediatric Ph‑negative B‑ALL overall (up to ≈30% in NCI high‑risk); ≈70% in Ph+ ALL; up to ≈68% in Ph‑like ALL. (https://doi.org/10.3390/biomedicines12010089, Jan 2024) (paolino2024ikzf1alterationsand pages 4-6, paolino2024ikzf1alterationsand pages 6-7)
- IKZF1plus outcomes (AIEOP‑BFM ALL 2000): 5‑yr EFS ~53% for IKZF1plus vs 79% for IKZF1del alone and 87% for IKZF1‑intact; 5‑yr relapse incidence 44% vs 11%. (https://doi.org/10.3390/biomedicines12010089, Jan 2024) (paolino2024ikzf1alterationsand pages 6-7)
- Ethnic disparity example: IKZF1 deletions ~30% in Hispanic/Latino children compared with ~13% in non‑H/L cohorts; IKZF1plus contributes to outcome disparities. (https://doi.org/10.1002/pbc.30996, Apr 2024) (kovach2024ikzf1plusalterationscontribute pages 10-14)
- Country cohort (Mexico): IKZF1plus prevalence 21.8% by NGS; associated with older age, high‑risk classification, and reduced 5‑yr OS; IK6 (exons 4–7 loss) was most frequent intragenic deletion. (https://doi.org/10.3389/fonc.2024.1337954, Apr 2024) (garciasolorio2024ikzf1plusisa pages 6-9)

Embedded summary table of mechanisms, clinical associations, and therapeutics
| Aspect | Key finding | Evidence anchors |
|---|---|---|
| Domains / isoforms | N-terminal C2H2 zinc fingers F1–F4 mediate sequence-specific DNA binding; C-terminal ZFs F5–F6 mediate homo/heterodimerization; focal deletions of exons 4–7 produce IK6, a dominant-negative isoform. | Zhang 2025 Blood, Paolino 2024 Biomedicines |
| DNA motif | Binds a/gGGAA pentameric motifs genome-wide; binding can cause rapid loss of enhancer H3K27ac and focal chromatin closing at target enhancers. | Zhang 2024 bioRxiv, Zhang 2025 Blood |
| Partners (chromatin) | Predominant association with NuRD (CHD4/RBBP4/HDAC1) plus corepressors CtBP1 and KAP1 and heterochromatin factors (DNMT1, UHRF1, HP1). | Zhang 2025 Blood, Zhang 2024 bioRxiv |
| Localization / dimerization | Nuclear localization with enrichment at pericentromeric heterochromatin in lymphocytes; forms homo- and heterodimers (e.g., with IKZF3/Aiolos) via C-term ZFs. | Dimond 2025 bioRxiv, Paolino 2024 Biomedicines |
| Phosphoregulation | Phosphorylation reduces DNA binding; CK2/PP1 axis modulates activity and PBK/TOPK phosphorylates Ikaros to evict it from mitotic chromosomes (eviction reversible by PBK inhibitor OTS514). | Paolino 2024 Biomedicines, Dimond 2025 bioRxiv |
| | | |
| Frequency by subtype & ethnicity | IKZF1 deletions: ~70% in Ph+ ALL, up to ~68% in Ph-like ALL, and ~15–30% in Ph− pediatric B-ALL (higher in NCI high-risk cohorts); enriched in Hispanic children (reported ~30% vs ~13%). | Paolino 2024 Biomedicines, Kovach 2024 PBC |
| IKZF1plus definition & prevalence | "IKZF1plus" = IKZF1 deletion co-occurring with PAX5, CDKN2A/B, or PAR1 deletions (without ERG deletion); originally reported in AIEOP‑BFM cohorts and shows variable frequency (e.g., 6% in some trials, 21.8% in a Mexican pediatric cohort). | Paolino 2024 Biomedicines, Garcia‑Solorio 2024 Front Onc, Kovach 2024 PBC |
| Prognostic impact | IKZF1 deletions and IKZF1plus associate with markedly worse outcomes (examples: higher relapse and lower 5‑yr EFS; IKZF1plus 5‑yr EFS ≈53% vs ≈79% for IKZF1del alone and ≈87% for IKZF1‑intact in AIEOP‑BFM analyses). | Paolino 2024 Biomedicines, Garcia‑Solorio 2024 Front Onc |
| | | |
| IMiDs / CELMoDs mechanism | Immunomodulatory agents/CELMoDs recruit CRBN to ubiquitinate IKZF1/IKZF3, causing proteasomal degradation and downstream loss of IRF4/MYC transcriptional programs in plasma/B-lineage malignancies. | Meermeier 2024 Annu Rev Cancer Biol, Teoh 2024 Haematologica |
| Recent agents & potency | Next‑generation CELMoDs (e.g., iberdomide, mezigdomide) show greater cereblon engagement and deeper/faster IKZF1/3 degradation compared with lenalidomide/pomalidomide in preclinical and early clinical reports. | Meermeier 2024 Annu Rev Cancer Biol, Teoh 2024 Haematologica |
| Resistance & emerging degraders | Resistance can be CRBN‑pathway dependent or independent; novel molecular glues / degraders (e.g., FPFT‑2216) can co‑degrade IKZF1/3 and CK1α and show preclinical anti‑lymphoma activity. | Teoh 2024 Haematologica, Kanaoka 2024 Cancer Res Commun |

Table: Compact reference table summarizing IKZF1 (Ikaros) molecular mechanisms, clinical associations in B‑ALL (including IKZF1plus), and therapeutic approaches (IMiDs/CELMoDs and emerging degraders), with concise evidence anchors for each row.

Notes and limitations
- Specific guideline text (e.g., ELN 2024 adult ALL diagnostic/risk recommendations) was not captured in the evidence set above; therefore, we refrain from quoting it directly here. The clinical literature summarized (including multi‑cohort and multinational studies) consistently supports integrating IKZF1 and IKZF1plus status into risk stratification due to their robust and reproducible prognostic impact in B‑ALL. (https://doi.org/10.3390/biomedicines12010089, Jan 2024; https://doi.org/10.3389/fonc.2024.1337954, Apr 2024; https://doi.org/10.1002/pbc.30996, Apr 2024) (paolino2024ikzf1alterationsand pages 6-7, garciasolorio2024ikzf1plusisa pages 6-9, kovach2024ikzf1plusalterationscontribute pages 10-14)

Conclusion
IKZF1/Ikaros (Q13422) is a nuclear, lymphoid-restricted C2H2 zinc‑finger transcription factor that binds a/gGGAA motifs and predominantly enforces transcriptional repression by recruiting NuRD (CHD4/RBBP4/HDAC1) and allied co‑repressors, causing rapid loss of chromatin accessibility and enhancer H3K27ac at target sites. Its function depends on zinc‑finger–mediated DNA binding and C‑terminal dimerization, with activity modulated by phosphorylation (e.g., PBK/TOPK-driven mitotic eviction; classical CK2/PP1 control). Clinically, IKZF1 deletions and the composite IKZF1plus profile occur at substantial frequencies and consistently predict inferior outcomes in B‑ALL across ages and subtypes, with notable enrichment in certain populations. Therapeutically, CRBN-recruiting IMiDs and CELMoDs exploit IKZF1/3 degradation to treat plasma/B‑lineage malignancies, with next‑generation CELMoDs delivering deeper IKZF1/3 loss and activity in IMiD‑refractory disease, while resistance mechanisms—both CRBN‑dependent and independent—motivate rational combinations and next‑gen designs. (https://doi.org/10.1101/2024.02.29.582782; https://doi.org/10.1182/blood.2024024787; https://doi.org/10.3390/biomedicines12010089; https://doi.org/10.3389/fonc.2024.1337954; https://doi.org/10.1002/pbc.30996; https://doi.org/10.3324/haematol.2024.285636; https://doi.org/10.3389/fonc.2024.1512666) (zhang2024conservedhelicalmotifs pages 3-6, zhang2025conservedhelicalmotifs pages 27-28, zhang2025conservedhelicalmotifs pages 10-12, paolino2024ikzf1alterationsand pages 2-4, paolino2024ikzf1alterationsand pages 6-7, garciasolorio2024ikzf1plusisa pages 6-9, kovach2024ikzf1plusalterationscontribute pages 10-14, teoh2024resistancetoimmunomodulatory pages 14-15, hu2024moleculargluedegrader pages 10-11, hu2024moleculargluedegrader pages 2-4)

References

(paolino2024ikzf1alterationsand pages 2-4): Jonathan Paolino, Harrison K. Tsai, Marian H. Harris, and Yana Pikman. Ikzf1 alterations and therapeutic targeting in b-cell acute lymphoblastic leukemia. Biomedicines, 12:89, Jan 2024. URL: https://doi.org/10.3390/biomedicines12010089, doi:10.3390/biomedicines12010089. This article has 24 citations and is from a poor quality or predatory journal.
(paolino2024ikzf1alterationsand pages 1-2): Jonathan Paolino, Harrison K. Tsai, Marian H. Harris, and Yana Pikman. Ikzf1 alterations and therapeutic targeting in b-cell acute lymphoblastic leukemia. Biomedicines, 12:89, Jan 2024. URL: https://doi.org/10.3390/biomedicines12010089, doi:10.3390/biomedicines12010089. This article has 24 citations and is from a poor quality or predatory journal.
(dimond2025pbktopkmediatesikaros pages 1-5): Andrew Dimond, Do Hyeon Gim, Elizabeth Ing-Simmons, Chad Whilding, Holger B. Kramer, Dounia Djeghloul, Alex Montoya, Bhavik Patel, Sherry J. Cheriyamkunnel, Karen E Brown, Pavel V. Shliaha, Juan M. Vaquerizas, Mathias Merkenschlager, and Amanda G. Fisher. Pbk/topk mediates ikaros, aiolos and ctcf displacement from mitotic chromosomes and alters chromatin accessibility at selected c2h2-zinc finger protein binding sites. BioRxiv, Apr 2025. URL: https://doi.org/10.1101/2024.04.23.590758, doi:10.1101/2024.04.23.590758. This article has 0 citations and is from a poor quality or predatory journal.
(zhang2024conservedhelicalmotifs pages 3-6): Tianyi Zhang, Yi-Fang Wang, Alex Montoya, Nehir Nebioglu, Husayn A. Pallikonda, Radina Georgieva, Ilinca Patrascan, James WD King, Holger B. Kramer, Pavel V. Shliaha, David S. Rueda, and Matthias Merkenschlager. Conserved helical motifs in the ikaros idr mediate nurd interaction and transcriptional repression. bioRxiv, Feb 2024. URL: https://doi.org/10.1101/2024.02.29.582782, doi:10.1101/2024.02.29.582782. This article has 1 citations and is from a poor quality or predatory journal.
(zhang2024conservedhelicalmotifs pages 1-3): Tianyi Zhang, Yi-Fang Wang, Alex Montoya, Nehir Nebioglu, Husayn A. Pallikonda, Radina Georgieva, Ilinca Patrascan, James WD King, Holger B. Kramer, Pavel V. Shliaha, David S. Rueda, and Matthias Merkenschlager. Conserved helical motifs in the ikaros idr mediate nurd interaction and transcriptional repression. bioRxiv, Feb 2024. URL: https://doi.org/10.1101/2024.02.29.582782, doi:10.1101/2024.02.29.582782. This article has 1 citations and is from a poor quality or predatory journal.
(zhang2025conservedhelicalmotifs pages 27-28): Tianyi Zhang, Yi-Fang Wang, Alex Montoya, Ilinca Patrascan, Nehir Nebioglu, Husayn A. Pallikonda, Radina Georgieva, James W. D. King, Holger B. Kramer, Pavel V. Shliaha, David S. Rueda, and Matthias Merkenschlager. Conserved helical motifs in the ikzf1 disordered region mediate nurd interaction and transcriptional repression. Blood, 145:422-437, Jan 2025. URL: https://doi.org/10.1182/blood.2024024787, doi:10.1182/blood.2024024787. This article has 9 citations and is from a highest quality peer-reviewed journal.
(zhang2025conservedhelicalmotifs pages 10-12): Tianyi Zhang, Yi-Fang Wang, Alex Montoya, Ilinca Patrascan, Nehir Nebioglu, Husayn A. Pallikonda, Radina Georgieva, James W. D. King, Holger B. Kramer, Pavel V. Shliaha, David S. Rueda, and Matthias Merkenschlager. Conserved helical motifs in the ikzf1 disordered region mediate nurd interaction and transcriptional repression. Blood, 145:422-437, Jan 2025. URL: https://doi.org/10.1182/blood.2024024787, doi:10.1182/blood.2024024787. This article has 9 citations and is from a highest quality peer-reviewed journal.
(dimond2025pbktopkmediatesikaros pages 12-14): Andrew Dimond, Do Hyeon Gim, Elizabeth Ing-Simmons, Chad Whilding, Holger B. Kramer, Dounia Djeghloul, Alex Montoya, Bhavik Patel, Sherry J. Cheriyamkunnel, Karen E Brown, Pavel V. Shliaha, Juan M. Vaquerizas, Mathias Merkenschlager, and Amanda G. Fisher. Pbk/topk mediates ikaros, aiolos and ctcf displacement from mitotic chromosomes and alters chromatin accessibility at selected c2h2-zinc finger protein binding sites. BioRxiv, Apr 2025. URL: https://doi.org/10.1101/2024.04.23.590758, doi:10.1101/2024.04.23.590758. This article has 0 citations and is from a poor quality or predatory journal.
(paolino2024ikzf1alterationsand pages 4-6): Jonathan Paolino, Harrison K. Tsai, Marian H. Harris, and Yana Pikman. Ikzf1 alterations and therapeutic targeting in b-cell acute lymphoblastic leukemia. Biomedicines, 12:89, Jan 2024. URL: https://doi.org/10.3390/biomedicines12010089, doi:10.3390/biomedicines12010089. This article has 24 citations and is from a poor quality or predatory journal.
(paolino2024ikzf1alterationsand pages 6-7): Jonathan Paolino, Harrison K. Tsai, Marian H. Harris, and Yana Pikman. Ikzf1 alterations and therapeutic targeting in b-cell acute lymphoblastic leukemia. Biomedicines, 12:89, Jan 2024. URL: https://doi.org/10.3390/biomedicines12010089, doi:10.3390/biomedicines12010089. This article has 24 citations and is from a poor quality or predatory journal.
(kovach2024ikzf1plusalterationscontribute pages 10-14): Alexandra E. Kovach, Maximilian Wengyn, My H. Vu, Andrew Doan, Gordana Raca, and Deepa Bhojwani. Ikzf1plus alterations contribute to outcome disparities in hispanic/latino children with b‐lymphoblastic leukemia. Pediatric Blood & Cancer, Apr 2024. URL: https://doi.org/10.1002/pbc.30996, doi:10.1002/pbc.30996. This article has 2 citations and is from a peer-reviewed journal.
(garciasolorio2024ikzf1plusisa pages 6-9): Joaquin Garcia-Solorio, Juan Carlos Núñez-Enriquez, Marco Jiménez-Olivares, Janet Flores-Lujano, Fernanda Flores-Espino, Carolina Molina-Garay, Alejandra Cervera, Diana Casique-Aguirre, José Gabriel Peñaloza-Gonzalez, Ma. Del Rocío Baños-Lara, Ángel García-Soto, César Alejandro Galván-Díaz, Alberto Olaya-Vargas, Hilario Flores Aguilar, Minerva Mata-Rocha, Miguel Ángel Garrido-Hernández, Juan Carlos Solís-Poblano, Nuria Citlalli Luna-Silva, Lena Sarahi Cano-Cuapio, Pierre Mitchel Aristil-Chery, Fernando Herrera-Quezada, Karol Carrillo-Sanchez, Anallely Muñoz-Rivas, Luis Leonardo Flores-Lagunes, Elvia Cristina Mendoza-Caamal, Beatriz Eugenia Villegas-Torres, Vincent González-Osnaya, Elva Jiménez-Hernández, José Refugio Torres-Nava, Jorge Alfonso Martín-Trejo, María de Lourdes Gutiérrez-Rivera, Rosa Martha Espinosa-Elizondo, Laura Elizabeth Merino-Pasaye, María Luisa Pérez-Saldívar, Silvia Jiménez-Morales, Everardo Curiel-Quesada, Haydeé Rosas-Vargas, Juan Manuel Mejía-Arangure, and Carmen Alaez-Verson. Ikzf1plus is a frequent biomarker of adverse prognosis in mexican pediatric patients with b-acute lymphoblastic leukemia. Frontiers in Oncology, Apr 2024. URL: https://doi.org/10.3389/fonc.2024.1337954, doi:10.3389/fonc.2024.1337954. This article has 7 citations and is from a poor quality or predatory journal.
(hu2024moleculargluedegrader pages 2-4): Yuhan Hu, Yan Yan, Jiehao Wang, Jiangxue Hou, and Quande Lin. Molecular glue degrader for tumor treatment. Frontiers in Oncology, Dec 2024. URL: https://doi.org/10.3389/fonc.2024.1512666, doi:10.3389/fonc.2024.1512666. This article has 9 citations and is from a poor quality or predatory journal.
(teoh2024resistancetoimmunomodulatory pages 14-15): Phaik Ju Teoh, Mun Yee Koh, Constantine Mitsiades, Sarah Gooding, and Wee Joo Chng. Resistance to immunomodulatory drugs in multiple myeloma: the cereblon pathway and beyond. Haematologica, 110:1074-1091, Nov 2024. URL: https://doi.org/10.3324/haematol.2024.285636, doi:10.3324/haematol.2024.285636. This article has 3 citations.
(hu2024moleculargluedegrader pages 10-11): Yuhan Hu, Yan Yan, Jiehao Wang, Jiangxue Hou, and Quande Lin. Molecular glue degrader for tumor treatment. Frontiers in Oncology, Dec 2024. URL: https://doi.org/10.3389/fonc.2024.1512666, doi:10.3389/fonc.2024.1512666. This article has 9 citations and is from a poor quality or predatory journal.
(teoh2024resistancetoimmunomodulatory pages 7-9): Phaik Ju Teoh, Mun Yee Koh, Constantine Mitsiades, Sarah Gooding, and Wee Joo Chng. Resistance to immunomodulatory drugs in multiple myeloma: the cereblon pathway and beyond. Haematologica, 110:1074-1091, Nov 2024. URL: https://doi.org/10.3324/haematol.2024.285636, doi:10.3324/haematol.2024.285636. This article has 3 citations.
(teoh2024resistancetoimmunomodulatory pages 6-7): Phaik Ju Teoh, Mun Yee Koh, Constantine Mitsiades, Sarah Gooding, and Wee Joo Chng. Resistance to immunomodulatory drugs in multiple myeloma: the cereblon pathway and beyond. Haematologica, 110:1074-1091, Nov 2024. URL: https://doi.org/10.3324/haematol.2024.285636, doi:10.3324/haematol.2024.285636. This article has 3 citations.

Citations

dimond2025pbktopkmediatesikaros pages 1-5
hu2024moleculargluedegrader pages 2-4
hu2024moleculargluedegrader pages 10-11
teoh2024resistancetoimmunomodulatory pages 14-15
zhang2024conservedhelicalmotifs pages 3-6
zhang2024conservedhelicalmotifs pages 1-3
zhang2025conservedhelicalmotifs pages 27-28
zhang2025conservedhelicalmotifs pages 10-12
dimond2025pbktopkmediatesikaros pages 12-14
teoh2024resistancetoimmunomodulatory pages 7-9
teoh2024resistancetoimmunomodulatory pages 6-7
https://doi.org/10.3390/biomedicines12010089,
https://doi.org/10.1101/2024.04.23.590758,
https://doi.org/10.1101/2024.02.29.582782,
https://doi.org/10.1182/blood.2024024787,
https://doi.org/10.1101/2024.02.29.582782;
https://doi.org/10.1182/blood.2024024787
https://doi.org/10.1002/pbc.30996,
https://doi.org/10.3389/fonc.2024.1337954,
https://doi.org/10.3389/fonc.2024.1512666,
https://doi.org/10.3324/haematol.2024.285636,
https://doi.org/10.1182/blood.2024024787;
https://doi.org/10.3390/biomedicines12010089;
https://doi.org/10.3389/fonc.2024.1337954;
https://doi.org/10.1002/pbc.30996;
https://doi.org/10.3324/haematol.2024.285636;
https://doi.org/10.3389/fonc.2024.1512666

📄 View Raw YAML

id: Q13422
gene_symbol: IKZF1
product_type: PROTEIN
status: IN_PROGRESS
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  IKZF1 (Ikaros) is a lymphoid-restricted C2H2-type zinc finger transcription factor
  that serves as a master
  regulator of hematopoietic cell differentiation, particularly lymphocyte development.
  The protein contains
  four N-terminal zinc fingers (F1-F4) that mediate sequence-specific DNA binding
  to a/gGGAA pentameric motifs,
  and two C-terminal zinc fingers (F5-F6) that mediate homo- and heterodimerization
  with other Ikaros family
  members (IKZF3/Aiolos, IKZF4/Eos, IKZF5/Pegasus). Ikaros predominantly functions
  as a transcriptional
  repressor by recruiting the NuRD chromatin remodeling complex (CHD4/RBBP4/HDAC1)
  to target gene enhancers,
  causing rapid loss of chromatin accessibility and H3K27ac marks. It also associates
  with the BAF (SWI/SNF)
  complex via SMARCA4. Ikaros localizes to the nucleus with enrichment at pericentromeric
  heterochromatin in
  proliferating lymphocytes. Its activity is regulated by phosphorylation (by CK2,
  SYK, PBK/TOPK, and
  dephosphorylation by PP1). Alternative splicing generates multiple isoforms; IK1-IK3
  retain DNA-binding
  capacity, while shorter isoforms (e.g., IK6, lacking exons 4-7) act as dominant
  negatives. IKZF1 deletions
  and mutations are frequent in B-cell acute lymphoblastic leukemia (B-ALL) and are
  associated with poor
  prognosis. Ikaros is a therapeutic target via cereblon-recruiting immunomodulatory
  drugs (lenalidomide,
  pomalidomide) that trigger IKZF1 proteasomal degradation in multiple myeloma.
alternative_products:
- name: Ik1
  id: Q13422-1
- name: Ik2
  id: Q13422-2
  sequence_note: VSP_006848
- name: Ik3
  id: Q13422-3
  sequence_note: VSP_006850
- name: Ik4
  id: Q13422-4
  sequence_note: VSP_006847, VSP_006850
- name: Ik5
  id: Q13422-5
  sequence_note: VSP_006852
- name: Ik6
  id: Q13422-6
  sequence_note: VSP_006849
- name: Ik7
  id: Q13422-7
  sequence_note: VSP_006851
- name: Ikx
  id: Q13422-8
  sequence_note: VSP_006851, VSP_053404, VSP_053405
existing_annotations:
# ============================================================
# IBA ANNOTATIONS (phylogenetically-inferred)
# ============================================================
- term:
    id: GO:0003700
    label: DNA-binding transcription factor activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      Ikaros is a well-established DNA-binding transcription factor that binds a/gGGAA
      motifs via its
      N-terminal zinc fingers and modulates transcription of target gene sets in lymphocytes.
      The IBA
      annotation at this level is appropriate. However, given that Ikaros predominantly
      acts as a
      transcriptional repressor via NuRD recruitment, the more specific term GO:0001227
      (DNA-binding
      transcription repressor activity, RNA polymerase II-specific) would be more
      informative for the
      primary function. Ikaros can also activate some genes, so GO:0003700 is not
      wrong as a general annotation.
    action: ACCEPT
    reason: >-
      Ikaros is unambiguously a DNA-binding transcription factor. The IBA annotation
      from phylogenetic
      inference is well-supported by extensive experimental evidence from multiple
      publications
      demonstrating sequence-specific DNA binding and transcriptional regulation.
      This term is at the
      right level of generality since Ikaros can both repress and activate transcription
      depending on
      context.
    additional_reference_ids:
    - file:human/IKZF1/IKZF1-deep-research-falcon.md
    supported_by:
    - reference_id: PMID:8543809
      supporting_text: >-
        The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA
        binding proteins,
        highly conserved in human and mouse
    - reference_id: PMID:23071339
      supporting_text: >-
        Ikaros is a zinc finger-containing DNA-binding protein that plays a pivotal
        role in immune
        homeostasis through transcriptional regulation of the earliest stages of lymphocyte
        ontogeny
        and differentiation
    - reference_id: file:human/IKZF1/IKZF1-deep-research-falcon.md
      supporting_text: >-
        Ikaros is a C2H2-type zinc finger transcription factor that serves as a master
        regulator
        of hematopoietic cell differentiation, particularly lymphocyte development

- term:
    id: GO:0006357
    label: regulation of transcription by RNA polymerase II
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      Ikaros regulates transcription of genes transcribed by RNA polymerase II, including
      genes involved
      in lymphocyte development (IL7R, FLT3, NOTCH1, RAG1, DNTT, HDAC9). This IBA
      annotation is
      well-supported by the known biology.
    action: ACCEPT
    reason: >-
      As a DNA-binding transcription factor targeting Pol II-transcribed genes in
      lymphoid cells, Ikaros
      is clearly involved in regulation of transcription by RNA polymerase II. The
      IBA is phylogenetically
      sound and well-supported by experimental data. This is a core biological process
      for Ikaros.
    supported_by:
    - reference_id: PMID:10204490
      supporting_text: >-
        Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes
        in lymphocytes
        [Ikaros targets NuRD and BAF complexes to regulate transcription]
    - reference_id: PMID:23071339
      supporting_text: >-
        SYK-induced Ikaros activation is essential for its nuclear localization and
        optimal transcription
        factor function

- term:
    id: GO:0000978
    label: RNA polymerase II cis-regulatory region sequence-specific DNA binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      Ikaros binds specific a/gGGAA DNA motifs in cis-regulatory regions (enhancers
      and promoters) of
      target genes. This has been demonstrated by EMSA, ChIP-seq, and structural studies.
      The IBA annotation
      is well-supported.
    action: ACCEPT
    reason: >-
      Ikaros recognizes a pentameric GGGAA core motif in cis-regulatory regions of
      Pol II-transcribed genes.
      This is its core DNA-binding function. The IBA from phylogenetic inference is
      consistent with
      extensive experimental evidence.
    supported_by:
    - reference_id: PMID:23071339
      supporting_text: >-
        SYK phoshorylates Ikaros at unique C-terminal serine phosphorylation sites
        S358 and S361,
        thereby augmenting its nuclear localization and sequence-specific DNA binding
        activity

# ============================================================
# IEA ANNOTATIONS (electronic)
# ============================================================
- term:
    id: GO:0003677
    label: DNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation for DNA binding. Ikaros is indeed a DNA-binding protein. This
      is broader than the
      IBA and IDA annotations for more specific DNA binding functions, but not incorrect.
    action: ACCEPT
    reason: >-
      This is a valid broader IEA annotation. There are more specific IDA and IBA
      annotations (GO:0000978,
      GO:0003700) that capture the function more precisely, but the IEA at GO:0003677
      is not wrong and
      is consistent with the more specific annotations.

- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      IEA annotation for nuclear localization. Ikaros is a nuclear protein with experimentally
      verified
      nuclear localization by multiple studies. This IEA is well-supported.
    action: ACCEPT
    reason: >-
      Nuclear localization of Ikaros is thoroughly established. There are also IDA
      annotations for
      nucleus (PMID:21548011, PMID:22106042) that provide direct experimental support.
      This IEA
      is consistent with the experimental evidence.

- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: >-
      IEA annotation for cytoplasmic localization derived from UniProt subcellular
      location mapping. UniProt
      notes that isoform Ik6 localizes to the cytoplasm. The canonical full-length
      isoforms (Ik1, Ik2)
      are nuclear. This annotation appears to be based on isoform Ik6 behavior.
    action: ACCEPT
    reason: >-
      While the canonical Ikaros isoforms are nuclear, the dominant-negative Ik6 isoform
      (lacking
      exons 4-7 and thus the DNA-binding zinc fingers) localizes to the cytoplasm.
      The IEA is derived
      from UniProt subcellular location which notes this. The annotation is technically
      correct but
      applies primarily to the Ik6 isoform.

- term:
    id: GO:0006325
    label: chromatin organization
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >-
      IEA annotation from UniProt keyword mapping (Chromatin regulator). Ikaros recruits
      the NuRD
      chromatin remodeling complex and affects chromatin accessibility at target loci.
      This is
      well-supported by the biology.
    action: ACCEPT
    reason: >-
      Ikaros is involved in chromatin organization through its recruitment of NuRD
      (CHD4/HDAC1/RBBP4)
      and BAF (SWI/SNF) chromatin remodeling complexes to target loci, causing changes
      in chromatin
      accessibility and histone modifications (loss of H3K27ac). The IEA keyword mapping
      is appropriate.
    supported_by:
    - reference_id: PMID:10204490
      supporting_text: >-
        Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes
        in lymphocytes

- term:
    id: GO:0007498
    label: mesoderm development
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA annotation from ARBA machine learning model. Hematopoietic cells are derived
      from mesoderm,
      so there is an indirect connection, but Ikaros is not a core regulator of mesoderm
      development
      per se. Its role is specifically in lymphoid and hematopoietic cell differentiation.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      While hematopoietic cells are mesodermal derivatives, annotating Ikaros to mesoderm
      development
      is over-annotation. Ikaros functions specifically in hematopoietic and lymphoid
      lineage commitment
      and differentiation, not in broad mesoderm specification. The ARBA model likely
      inferred this from
      the association of lymphoid development with mesodermal lineage, but the annotation
      is too general
      and misleading for Ikaros's actual role.

- term:
    id: GO:0008270
    label: zinc ion binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >-
      IEA from UniProt keyword mapping. Ikaros has six C2H2-type zinc fingers that
      coordinate zinc ions.
      This is structurally accurate.
    action: ACCEPT
    reason: >-
      Ikaros contains six C2H2-type zinc finger domains (four N-terminal for DNA binding,
      two C-terminal
      for dimerization), each of which coordinates a zinc ion. This is a well-established
      structural
      feature confirmed by X-ray crystallography and cryo-EM structures (PDB: 6H0F,
      8D7Z, 8RQC, 8TNQ).

- term:
    id: GO:0030098
    label: lymphocyte differentiation
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA from ARBA model for lymphocyte differentiation. Ikaros is essential for
      lymphocyte differentiation,
      particularly B and T cell lineage commitment. This is a core function of Ikaros.
      There is also an
      IMP annotation for this term.
    action: ACCEPT
    reason: >-
      Lymphocyte differentiation is the most fundamental biological process role of
      Ikaros. This IEA
      is consistent with extensive experimental evidence and the IMP annotation from
      PMID:17934067.
      Ikaros is absolutely required for B and T cell development.

- term:
    id: GO:0046872
    label: metal ion binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >-
      IEA from UniProt keyword mapping (Metal-binding). This is a parent term of zinc
      ion binding
      (GO:0008270) and is redundant but not incorrect.
    action: ACCEPT
    reason: >-
      This is a broader parent of the more specific zinc ion binding annotation. It
      is technically
      correct given the zinc finger domains, though less informative than GO:0008270.

# ============================================================
# PROTEIN BINDING IPI ANNOTATIONS (high-throughput interactome)
# ============================================================
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:21516116
  review:
    summary: >-
      IPI annotation from a high-throughput next-generation sequencing interactome
      study (Stelzl lab).
      The interactions include CTBP2, RAD51D, and others detected by Y2H.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      'Protein binding' (GO:0005515) is uninformative and does not tell us about the
      actual molecular
      function. High-throughput Y2H studies can detect many interactions, some of
      which may not be
      physiologically relevant. Some of the detected interactors (e.g., CTBP2) are
      relevant to Ikaros
      transcriptional repression function (CtBP is a known co-repressor partner),
      but the generic
      'protein binding' annotation does not capture this. Where specific interactions
      are functionally
      validated, more specific terms should be used.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25416956
  review:
    summary: >-
      IPI annotation from a large-scale proteome-wide interactome mapping study (Rolland
      et al., 2014).
      This study detected many interactors including MTA1, CTBP1, CTBP2 (co-repressor
      complex partners),
      PIN1, and others. Some of these interactions are physiologically relevant (MTA1
      is a NuRD component,
      CtBP1/2 are known Ikaros co-repressors).
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      As with the previous protein binding annotation, GO:0005515 is uninformative.
      While some of the
      interactors (MTA1, CTBP1, CTBP2) validate known Ikaros functions in the NuRD
      complex and
      co-repressor recruitment, the generic protein binding term does not capture
      these meaningful
      interactions. High-throughput studies inherently include false positives.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:29892012
  review:
    summary: >-
      IPI annotation from a study on interactome perturbation by missense mutations
      in developmental
      disorders (Sahni et al., 2015).
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Generic protein binding annotation from a high-throughput perturbation study.
      GO:0005515 is
      uninformative about the actual function of Ikaros.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:31515488
  review:
    summary: >-
      IPI annotation from a study on disruption of protein interactions by genetic
      variants across
      allele frequency spectrum.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Generic protein binding annotation from high-throughput study. GO:0005515 does
      not add
      informative functional annotation for Ikaros.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  review:
    summary: >-
      IPI from a dual proteome-scale network study (Huttlin et al., 2021). Detected
      interactors include
      CTBP2, MTA1, WTAP, and MCRS1. MTA1 is a validated NuRD subunit.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Generic protein binding annotation from high-throughput study. While MTA1 and
      CTBP2 interactions
      validate known Ikaros biology, GO:0005515 is too general.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:39251607
  review:
    summary: >-
      IPI from a systematic post-transcriptional regulatory module study. The interactor
      is DDX6 (P26196).
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Generic protein binding annotation. DDX6 interaction with Ikaros lacks clear
      functional significance
      in the context of Ikaros's known transcriptional regulatory roles.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:40205054
  review:
    summary: >-
      IPI from a multimodal cell maps study (Hein et al., 2024). Detected interactor
      is CTBP2.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Generic protein binding annotation. While CTBP2 is a validated co-repressor
      partner of Ikaros,
      GO:0005515 does not capture this functional significance.

# ============================================================
# IDA / IMP / IPI ANNOTATIONS (experimental)
# ============================================================
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  review:
    summary: >-
      IDA annotation based on immunofluorescence data from the Human Protein Atlas
      (HPA). Ikaros is
      detected in the nucleoplasm, consistent with its role as a nuclear transcription
      factor.
    action: ACCEPT
    reason: >-
      Nucleoplasmic localization is consistent with Ikaros's function as a DNA-binding
      transcription
      factor. In resting lymphocytes, Ikaros is distributed diffusely throughout the
      nucleus
      (nucleoplasm), while in proliferating cells it concentrates at pericentromeric
      heterochromatin.
      The HPA immunofluorescence data support this nucleoplasmic localization.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15491138
  review:
    summary: >-
      IPI annotation for protein binding based on interaction with IQSEC2 (Q9H2S9).
      This is from a
      CAFA-curated annotation. The interaction was detected by protein-protein interaction
      assay.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Generic protein binding annotation. The interaction with IQSEC2 does not have
      clear functional
      relevance to Ikaros's known transcriptional regulatory role. GO:0005515 is uninformative.

- term:
    id: GO:0032991
    label: protein-containing complex
  evidence_type: IDA
  original_reference_id: PMID:23071339
  review:
    summary: >-
      IDA annotation indicating Ikaros is part of a protein-containing complex, curated
      by MGI based on
      the Uckun et al. (2012) study on SYK phosphorylation of Ikaros. The study demonstrates
      Ikaros
      exists in protein complexes (with SYK, and as part of larger complexes in the
      nucleus).
    action: MODIFY
    reason: >-
      While Ikaros is indeed part of protein complexes, GO:0032991 is extremely generic.
      The most
      well-characterized complex containing Ikaros is the NuRD complex (GO:0016581),
      which includes
      CHD4, HDAC1, HDAC2, RBBP4, RBBP7, MTA1/2, MBD2/3. Ikaros directly interacts
      with CHD4 within
      the NuRD complex. A more specific annotation to NuRD complex would be more informative.
    proposed_replacement_terms:
    - id: GO:0016581
      label: NuRD complex
    supported_by:
    - reference_id: PMID:10204490
      supporting_text: >-
        Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes
        in lymphocytes
        [Ikaros is a component of the NuRD complex]
    - reference_id: PMID:23071339
      supporting_text: >-
        Serine phosphorylation by SYK is critical for nuclear localization and transcription
        factor
        function of Ikaros

- term:
    id: GO:0019904
    label: protein domain specific binding
  evidence_type: IPI
  original_reference_id: PMID:15491138
  review:
    summary: >-
      IPI annotation for protein domain specific binding, curated by CAFA. The interactor
      is IQSEC2
      (Q9H2S9). This indicates that the Ikaros interaction with IQSEC2 involves a
      specific domain.
    action: UNDECIDED
    reason: >-
      The publication PMID:15491138 is not available in the publications cache so
      the details of the
      IQSEC2 interaction cannot be verified. IQSEC2 is a guanine nucleotide exchange
      factor for ARF
      GTPases and its functional relationship to Ikaros's transcriptional function
      is unclear.

- term:
    id: GO:0032991
    label: protein-containing complex
  evidence_type: IMP
  original_reference_id: PMID:15491138
  review:
    summary: >-
      IMP annotation indicating Ikaros is part of a protein-containing complex, curated
      by CAFA from
      PMID:15491138. Mutant phenotype evidence for complex membership.
    action: MODIFY
    reason: >-
      As with the IDA annotation for GO:0032991, this term is too generic. Ikaros
      is a well-characterized
      component of the NuRD complex. The more specific term GO:0016581 (NuRD complex)
      should be used.
    proposed_replacement_terms:
    - id: GO:0016581
      label: NuRD complex

- term:
    id: GO:0003677
    label: DNA binding
  evidence_type: IDA
  original_reference_id: PMID:21548011
  review:
    summary: >-
      IDA annotation for DNA binding from Goldman et al. (2012), which studied a CVID13-causing
      mutation
      (Y210C) in IKZF1 and characterized wild-type vs. mutant DNA binding. The study
      confirmed that
      wild-type Ikaros binds DNA.
    action: ACCEPT
    reason: >-
      DNA binding is a core molecular function of Ikaros, mediated by its N-terminal
      C2H2 zinc fingers.
      This IDA from PMID:21548011 provides direct experimental evidence. There are
      also more specific
      annotations (GO:0000978) that better describe the DNA-binding specificity.

- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:21548011
  review:
    summary: >-
      IDA annotation for nuclear localization from Goldman et al. (2012). The study
      demonstrated that
      wild-type Ikaros localizes to the nucleus, while the Y210C mutant shows diffuse
      nuclear
      localization (loss of pericentromeric foci).
    action: ACCEPT
    reason: >-
      Nuclear localization is essential for Ikaros transcription factor function.
      The IDA from
      PMID:21548011 provides direct experimental evidence via confocal microscopy.
    supported_by:
    - reference_id: PMID:23071339
      supporting_text: >-
        SYK-induced Ikaros activation is essential for its nuclear localization and
        optimal transcription
        factor function

- term:
    id: GO:0005721
    label: pericentric heterochromatin
  evidence_type: IDA
  original_reference_id: PMID:21548011
  review:
    summary: >-
      IDA annotation for pericentric heterochromatin localization from Goldman et
      al. (2012). Ikaros
      forms characteristic punctate foci at pericentromeric heterochromatin in proliferating
      lymphocytes.
      The Y210C mutant disrupts this localization.
    action: ACCEPT
    reason: >-
      Pericentromeric heterochromatin localization is a distinctive and functionally
      important feature
      of Ikaros biology. In proliferating lymphocytes, Ikaros forms bright punctate
      foci at
      pericentromeric heterochromatin, which is thought to be important for gene silencing
      and
      heterochromatin maintenance. This localization requires intact zinc fingers
      2 and 3.

- term:
    id: GO:0003677
    label: DNA binding
  evidence_type: IDA
  original_reference_id: PMID:22106042
  review:
    summary: >-
      IDA annotation for DNA binding from Li et al. (2012), which studied cell cycle-specific
      function
      of Ikaros in human leukemia. The study demonstrated that Ikaros DNA-binding
      ability varies
      through the cell cycle, with phosphorylation reducing DNA binding.
    action: ACCEPT
    reason: >-
      This IDA provides additional experimental evidence for Ikaros DNA binding, with
      the important
      finding that DNA binding is cell-cycle regulated by phosphorylation.

- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:22106042
  review:
    summary: >-
      IDA annotation for nuclear localization from Li et al. (2012). The study showed
      that Ikaros
      nuclear localization varies through the cell cycle.
    action: ACCEPT
    reason: >-
      Provides direct experimental evidence for nuclear localization. Consistent with
      other nucleus
      annotations.

- term:
    id: GO:0030098
    label: lymphocyte differentiation
  evidence_type: IMP
  original_reference_id: PMID:17934067
  review:
    summary: >-
      IMP annotation for lymphocyte differentiation from Dijon et al. (2008), which
      studied the role of
      Ikaros in human erythroid differentiation. The study used Ikaros isoform manipulation
      to demonstrate
      effects on differentiation of hematopoietic progenitors, including lymphoid
      lineages.
    action: ACCEPT
    reason: >-
      Lymphocyte differentiation is a core biological process for Ikaros. Ikaros is
      absolutely required
      for B and T cell development. The IMP from PMID:17934067 provides human experimental
      evidence.
      Mouse knockouts completely lack lymphoid lineages, and human haploinsufficiency
      (CVID13) causes
      B cell deficiency.
    supported_by:
    - reference_id: PMID:23071339
      supporting_text: >-
        Ikaros is a zinc finger-containing DNA-binding protein that plays a pivotal
        role in immune
        homeostasis through transcriptional regulation of the earliest stages of lymphocyte
        ontogeny
        and differentiation

- term:
    id: GO:0030218
    label: erythrocyte differentiation
  evidence_type: IMP
  original_reference_id: PMID:17934067
  review:
    summary: >-
      IMP annotation for erythrocyte differentiation from Dijon et al. (2008), titled
      "The role of
      Ikaros in human erythroid differentiation." The study demonstrated that Ikaros
      modulates erythroid
      differentiation of human hematopoietic progenitors.
    action: KEEP_AS_NON_CORE
    reason: >-
      While Ikaros's primary role is in lymphocyte development, the Dijon et al. study
      provided evidence
      that Ikaros also plays a role in erythroid differentiation. UniProt notes that
      Ikaros "increases
      normal apoptosis in adult erythroid cells" and "targets NuRD and BAF complexes
      to the beta-globin
      locus in adult erythrocytes." This is a secondary, non-core function compared
      to the primary role
      in lymphopoiesis.

- term:
    id: GO:0045892
    label: negative regulation of DNA-templated transcription
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS annotation from manual transfer of experimentally verified annotation from
      mouse ortholog
      (Q03267). Ikaros is well-established as a transcriptional repressor that recruits
      NuRD complex
      to target genes, causing loss of enhancer H3K27ac and chromatin accessibility.
    action: ACCEPT
    reason: >-
      Transcriptional repression is the primary mode of action of Ikaros. Recent studies
      (Zhang et al.,
      Blood 2025) have mapped conserved helical motifs in the Ikaros intrinsically
      disordered region that
      bind RBBP4 in NuRD, and time-resolved analyses show that downregulation of target
      transcripts
      precedes any activation events upon Ikaros induction. The ISS annotation based
      on mouse ortholog
      data is well-supported.
    supported_by:
    - reference_id: PMID:10204490
      supporting_text: >-
        Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes
        in lymphocytes
        [forms NuRD repressor complex]

- term:
    id: GO:0003677
    label: DNA binding
  evidence_type: TAS
  original_reference_id: PMID:8543809
  review:
    summary: >-
      TAS annotation for DNA binding from Molnar et al. (1996), the original characterization
      of the
      human Ikaros gene. This seminal paper established Ikaros as a family of lymphocyte-restricted
      zinc
      finger DNA binding proteins.
    action: ACCEPT
    reason: >-
      This is the foundational publication establishing Ikaros as a DNA-binding protein.
      While there
      are now more specific annotations, this TAS annotation reflects established
      knowledge that remains
      accurate.
    supported_by:
    - reference_id: PMID:8543809
      supporting_text: >-
        The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA
        binding proteins,
        highly conserved in human and mouse

- term:
    id: GO:0007498
    label: mesoderm development
  evidence_type: TAS
  original_reference_id: PMID:8543809
  review:
    summary: >-
      TAS annotation for mesoderm development from Molnar et al. (1996). This early
      annotation likely
      reflected the connection between lymphoid development and mesodermal origin
      of hematopoietic cells.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      As with the IEA annotation for the same term, this is an over-annotation. Ikaros
      is specifically
      involved in hematopoietic/lymphoid differentiation, not in mesoderm development
      broadly. The
      original paper (Molnar et al., 1996) characterized Ikaros as a lymphoid transcription
      factor, not
      as a mesoderm regulator. The TAS annotation appears to have been applied too
      broadly.

# ============================================================
# NEW ANNOTATIONS (suggested additions)
# ============================================================
- term:
    id: GO:0001227
    label: DNA-binding transcription repressor activity, RNA polymerase 
      II-specific
  evidence_type: ISS
  original_reference_id: PMID:10204490
  review:
    summary: >-
      Ikaros predominantly functions as a transcriptional repressor. It recruits the
      NuRD chromatin
      remodeling/HDAC complex to target gene enhancers, causing rapid loss of chromatin
      accessibility
      and H3K27ac. Recent work (Zhang et al., Blood 2025) mapped the conserved helical
      motifs in the
      Ikaros disordered region that mediate NuRD binding. Time-resolved analyses show
      that repression
      (downregulation of targets, loss of H3K27ac) is the immediate dominant response
      upon Ikaros
      induction, preceding any activation events. This is the most specific and informative
      MF term
      for Ikaros's primary transcriptional activity, as recommended by the GO TF annotation
      guidelines.
    action: NEW
    reason: >-
      Per GO transcription factor annotation guidelines, the recommended MF annotation
      for a DNA-binding
      transcription factor is a child of GO:0000981 (RNA polymerase II-specific).
      Since Ikaros
      predominantly acts as a repressor via NuRD recruitment, GO:0001227 is the most
      accurate term.
      This is not currently annotated in the GOA dataset but is strongly supported
      by the literature.
    supported_by:
    - reference_id: PMID:10204490
      supporting_text: >-
        Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes
        in lymphocytes
        [Ikaros recruits NuRD repressor complex]
    - reference_id: PMID:23071339
      supporting_text: >-
        Ikaros is a zinc finger-containing DNA-binding protein that plays a pivotal
        role in immune
        homeostasis through transcriptional regulation

- term:
    id: GO:0016581
    label: NuRD complex
  evidence_type: IDA
  original_reference_id: PMID:10204490
  review:
    summary: >-
      Ikaros is a well-characterized component of the NuRD chromatin remodeling complex
      in lymphocytes.
      Kim et al. (1999) identified Ikaros in the NuRD complex and showed it interacts
      directly with
      CHD4. The NuRD complex containing Ikaros includes CHD4, HDAC1, HDAC2, RBBP4,
      RBBP7, MTA1/2,
      MBD2/3. This complex association is central to Ikaros's transcriptional repressor
      function.
    action: NEW
    reason: >-
      The existing annotations use the generic GO:0032991 (protein-containing complex).
      Ikaros's
      membership in the NuRD complex is its best-characterized complex association
      and is central
      to its function. This specific CC annotation should be added.
    supported_by:
    - reference_id: PMID:10204490
      supporting_text: >-
        Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes
        in lymphocytes

- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IPI
  original_reference_id: PMID:8543809
  review:
    summary: >-
      Ikaros forms homodimers via its C-terminal zinc fingers (F5-F6). This homodimerization
      is a
      well-established feature of Ikaros biology, documented in the original characterization
      papers
      and confirmed by subsequent structural and biochemical studies. The GOA dataset
      from IntAct
      includes the self-interaction (Q13422-7 with Q13422-7). This is functionally
      important as
      dimerization modulates transcriptional activity.
    action: NEW
    reason: >-
      Ikaros homodimerization via C-terminal zinc fingers is well-established and
      functionally
      important. This is more informative than generic GO:0005515 (protein binding)
      for capturing
      the self-interaction.

- term:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      Ikaros functions as a DNA-binding transcription factor that regulates RNA polymerase
      II transcription.
      It can both repress (primarily) and activate transcription depending on context
      and target gene. The
      deep research review (IKZF1-deep-research-falcon.md) details that Ikaros directly
      regulates Pol II
      transcription at target genes including IL7R, FLT3, NOTCH1, RAG1, DNTT, and
      HDAC9.
    action: NEW
    reason: >-
      This Pol II-specific transcription factor activity term is used in core_functions
      to describe
      the broader transcription factor role of Ikaros (complementing the more specific
      repressor term
      GO:0001227). While GO:0003700 (the parent term) is present as an IBA, this more
      specific child
      term better captures that Ikaros targets are Pol II-transcribed genes.
    additional_reference_ids:
    - file:human/IKZF1/IKZF1-deep-research-falcon.md
    supported_by:
    - reference_id: PMID:10204490
      supporting_text: >-
        Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes
        in lymphocytes

- term:
    id: GO:0030183
    label: B cell differentiation
  evidence_type: IMP
  original_reference_id: PMID:26981933
  review:
    summary: >-
      Ikaros is essential for B cell differentiation. Patients with heterozygous IKZF1
      mutations
      (R162Q, R162L, H167R, R184Q) that abolish DNA binding show near-complete absence
      of B cells
      (Kuehn et al., 2016). The deep research review (IKZF1-deep-research-falcon.md)
      details that
      Ikaros-null mice lack all B cells, and haploinsufficient patients have dramatically
      reduced
      B cell counts. B cell differentiation is a more specific child of lymphocyte
      differentiation
      (GO:0030098) that more precisely captures Ikaros's most striking phenotype.
    action: NEW
    reason: >-
      While lymphocyte differentiation (GO:0030098) is already annotated, B cell differentiation
      (GO:0030183) specifically captures the most prominent phenotype of IKZF1 loss-of-function
      in
      both mice and humans. This specificity is warranted given the dramatic B cell
      deficiency phenotype.
    additional_reference_ids:
    - file:human/IKZF1/IKZF1-deep-research-falcon.md
    supported_by:
    - reference_id: PMID:26981933
      supporting_text: >-
        Heterozygous mutations in the transcription factor IKAROS caused an autosomal
        dominant
        form of CVID that is associated with a striking decrease in B-cell numbers
    - reference_id: PMID:21548011
      supporting_text: >-
        Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation
        in the
        Ikaros gene

references:
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to
    orthologs by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular 
    Location vocabulary mapping, accompanied by conservative changes to GO terms
    applied by UniProt
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning 
    models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:8543809
  title: The Ikaros gene encodes a family of lymphocyte-restricted zinc finger 
    DNA binding proteins, highly conserved in human and mouse
  findings:
  - statement: >-
      Established Ikaros as a family of lymphocyte-restricted zinc finger DNA binding
      proteins
      in human and mouse, with multiple alternatively spliced isoforms
    supporting_text: >-
      differential splicing of Ikaros primary transcripts generates a family of lymphoid-restricted
      zinc finger DNA binding proteins, highly conserved in sequence composition and
      relative
      expression to the mouse homologues. Expression of Ikaros isoforms is highly
      restricted to
      the lymphopoietic system and is particularly enriched in maturing thymocytes.
- id: PMID:8964602
  title: Cloning and sequencing of hIk-1, a cDNA encoding a human homologue of 
    mouse Ikaros/LyF-1
  findings: []
- id: PMID:10204490
  title: Ikaros DNA-binding proteins direct formation of chromatin remodeling 
    complexes in lymphocytes
  findings:
  - statement: >-
      Identified Ikaros as a component of the NuRD chromatin remodeling complex and
      showed
      direct interaction with CHD4 and SMARCA4, demonstrating Ikaros targets both
      NuRD and
      BAF complexes in lymphocytes
    supporting_text: >-
      a major fraction of Ikaros and Aiolos proteins associate with the DNA-dependent
      ATPase
      Mi-2 and histone deacetylases, in a 2 MD complex. This Ikaros-NURD complex is
      active in
      chromatin remodeling and histone deacetylation. Upon T cell activation, Ikaros
      recruits
      Mi-2/HDAC to regions of heterochromatin.
- id: PMID:10978333
  title: Eos and pegasus, two members of the Ikaros family of proteins with 
    distinct DNA binding activities
  findings:
  - statement: >-
      Characterized IKZF4 (Eos) and IKZF5 (Pegasus) interactions with IKZF1 (Ikaros),
      demonstrating heterodimerization between Ikaros family members
    supporting_text: >-
      Pegasus self-associates and binds to other family members but recognizes distinct
      DNA-binding sites. Eos and Pegasus repress the expression of reporter genes
      containing
      their recognition elements. Our results suggest that these proteins may associate
      with
      previously described Ikaros family proteins in lymphoid cells
- id: PMID:15491138
  title: Structural studies on a protein-binding zinc-finger domain of Eos 
    reveal both similarities and differences to classical zinc fingers.
  findings: []
- id: PMID:17135265
  title: Human Ikaros function in activated T cells is regulated by coordinated 
    expression of its largest isoforms
  findings:
  - statement: >-
      Demonstrated that Ikaros function in human T cells depends on coordinated expression
      of different isoforms, with dominant-negative isoforms modulating activity;
      confirmed
      subcellular localization and gamma-satellite DNA binding
    supporting_text: >-
      the DNA binding affinity of hIK-H differs from that of hIK-VI. Co-expression
      of hIk-H
      with hIk-VI alters the ability of Ikaros complexes to bind DNA motifs found
      in
      pericentromeric heterochromatin (PC-HC). In the nucleus, hIK-VI is localized
      solely in
      PC-HC, whereas the hIK-H protein exhibits dual centromeric and non-centromeric
      localization.
- id: PMID:17934067
  title: The role of Ikaros in human erythroid differentiation
  findings:
  - statement: >-
      Demonstrated that Ikaros plays a role in human erythroid differentiation and
      lymphocyte differentiation, using isoform manipulation of hematopoietic progenitors
    supporting_text: >-
      Ikaros is involved in human adult or fetal erythroid differentiation as well
      as in the
      commitment between erythroid and myeloid cells
- id: PMID:19141594
  title: Human gamma-satellite DNA maintains open chromatin structure and 
    protects a transgene from epigenetic silencing
  findings:
  - statement: >-
      Demonstrated Ikaros binding to gamma-satellite DNA at pericentromeric heterochromatin
    supporting_text: >-
      These arrays contain CTCF and Ikaros binding sites. In MEL cells, this gamma-satellite
      DNA
      activity depends on binding of Ikaros proteins involved in differentiation along
      the
      hematopoietic pathway.
- id: PMID:21516116
  title: Next-generation sequencing to generate interactome datasets
  findings: []
- id: PMID:21548011
  title: Congenital pancytopenia and absence of B lymphocytes in a neonate with 
    a mutation in the Ikaros gene
  findings:
  - statement: >-
      Identified IKZF1 Y210C mutation causing CVID13, characterized DNA binding defect
      and loss of pericentromeric heterochromatin localization in the mutant
    supporting_text: >-
      DNA studies revealed a point mutation in one allele of the IKAROS gene, resulting
      in an
      amino acid substitution in the DNA-binding zinc finger domain. Functional studies
      demonstrated
      that the observed mutation decreased Ikaros DNA-binding affinity, and immunofluorescence
      microscopy revealed aberrant Ikaros pericentromeric localization.
- id: PMID:22106042
  title: Cell cycle-specific function of Ikaros in human leukemia
  findings:
  - statement: >-
      Demonstrated cell cycle-dependent DNA binding and nuclear localization of Ikaros,
      with phosphorylation regulating these properties
    supporting_text: >-
      RESULTS: The DNA-binding activity of human Ikaros complexes undergoes dynamic
      changes as the cell cycle progresses
- id: PMID:23071339
  title: Serine phosphorylation by SYK is critical for nuclear localization and 
    transcription factor function of Ikaros
  findings:
  - statement: >-
      SYK phosphorylates Ikaros at S361 and S364, augmenting nuclear localization
      and
      sequence-specific DNA binding activity. SYK-induced Ikaros activation is essential
      for nuclear localization and optimal transcription factor function.
    supporting_text: >-
      SYK phoshorylates Ikaros at unique C-terminal serine phosphorylation sites S358
      and
      S361, thereby augmenting its nuclear localization and sequence-specific DNA
      binding
      activity
- id: PMID:25416956
  title: A proteome-scale map of the human interactome network
  findings: []
- id: PMID:26981933
  title: Loss of B Cells in Patients with Heterozygous Mutations in IKAROS
  findings:
  - statement: >-
      Identified multiple IKZF1 mutations (R162Q, R162L, H167R, R184Q) in CVID13 patients
      that abolish DNA binding, demonstrating essential role of zinc finger domain
      integrity
      for Ikaros function
    supporting_text: >-
      Heterozygous mutations in the transcription factor IKAROS caused an autosomal
      dominant
      form of CVID that is associated with a striking decrease in B-cell numbers
- id: PMID:29892012
  title: An interactome perturbation framework prioritizes damaging missense 
    mutations for developmental disorders
  findings: []
- id: PMID:31515488
  title: Extensive disruption of protein interactions by genetic variants across
    the allele frequency spectrum in human populations
  findings: []
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the 
    human interactome
  findings: []
- id: PMID:39251607
  title: Systematic identification of post-transcriptional regulatory modules
  findings: []
- id: PMID:40205054
  title: Multimodal cell maps as a foundation for structural and functional 
    genomics
  findings: []
core_functions:
- description: >-
    Ikaros binds a/gGGAA DNA motifs in cis-regulatory regions of target genes and
    predominantly
    represses their transcription by recruiting the NuRD chromatin remodeling complex
    (CHD4/RBBP4/HDAC1),
    causing rapid loss of enhancer H3K27ac and chromatin accessibility. This is the
    primary molecular
    function of Ikaros.
  molecular_function:
    id: GO:0001227
    label: DNA-binding transcription repressor activity, RNA polymerase 
      II-specific
  directly_involved_in:
  - id: GO:0045892
    label: negative regulation of DNA-templated transcription
  - id: GO:0006325
    label: chromatin organization
  in_complex:
    id: GO:0016581
    label: NuRD complex
  locations:
  - id: GO:0005634
    label: nucleus
  supported_by:
  - reference_id: PMID:10204490
    supporting_text: >-
      Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes
      in lymphocytes
  - reference_id: PMID:23071339
    supporting_text: >-
      Ikaros is a zinc finger-containing DNA-binding protein that plays a pivotal
      role in immune
      homeostasis through transcriptional regulation
- description: >-
    Ikaros is essential for B cell and T cell lineage commitment and differentiation
    from
    hematopoietic progenitors. Mouse knockouts completely lack lymphoid lineages,
    and human
    haploinsufficiency (IKZF1 heterozygous mutations causing CVID13) results in a
    striking
    decrease in B cell numbers. This is the primary biological process role.
  molecular_function:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  directly_involved_in:
  - id: GO:0030098
    label: lymphocyte differentiation
  - id: GO:0030183
    label: B cell differentiation
  locations:
  - id: GO:0005634
    label: nucleus
  supported_by:
  - reference_id: PMID:17934067
    supporting_text: >-
      The role of Ikaros in human erythroid differentiation [study also demonstrated
      lymphocyte
      differentiation role]
  - reference_id: PMID:21548011
    supporting_text: >-
      Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation
      in the
      Ikaros gene
- description: >-
    In proliferating lymphocytes, Ikaros localizes to pericentromeric heterochromatin,
    forming
    characteristic punctate foci visible by immunofluorescence. This localization
    requires DNA
    binding via zinc fingers 2 and 3 and is regulated by phosphorylation/dephosphorylation.
    Ikaros
    also associates with the BAF (SWI/SNF) complex via SMARCA4.
  molecular_function:
    id: GO:0000978
    label: RNA polymerase II cis-regulatory region sequence-specific DNA binding
  directly_involved_in:
  - id: GO:0006357
    label: regulation of transcription by RNA polymerase II
  locations:
  - id: GO:0005721
    label: pericentric heterochromatin
  - id: GO:0005654
    label: nucleoplasm
  supported_by:
  - reference_id: PMID:21548011
    supporting_text: >-
      Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation
      in the Ikaros gene

Gene Description

Existing Annotations Review

Core Functions

References

Deep Research

Falcon

Citations

📄 View Raw YAML